System-level analyses to identify macrophage-specific mechanisms controlling skeletal muscle regeneration by Patsalos, Andreas
SHORT	THESIS	FOR	THE	DEGREE	OF	DOCTOR	PHILOSOPHY	(PhD)	
	
	
	
	
System-level	analyses	to	identify	macrophage-specific	
mechanisms	controlling	skeletal	muscle	regeneration	
	
	
by	Andreas	Patsalos		
	
	
Supervisor:	Professor	Dr.	László	Nagy	
	
	
	
	
	
	
UNIVERSITY	OF	DEBRECEN	
	
DOCTORAL	SCHOOL	OF	MOLECULAR	CELL		
AND	IMMUNE	BIOLOGY	
	
	
DEBRECEN,	2017	
	
	
	 2	
System-level	analyses	to	identify	macrophage-specific	mechanisms	controlling	skeletal	muscle	
regeneration	
By	Andreas	Patsalos,	MSc		
Supervisor:	Prof.	László	Nagy,	MD,	PhD,	DSc,	member	of	HAS	
Doctoral	School	of	Molecular	Cell	and	Immune	Biology,	University	of	Debrecen		
	
Head	of	the	Examination	Committee:		 Prof.	Gábor	Szabó,	MD,	PhD,	DSc	
Members	of	the	Examination	Committee:		 Prof.	Sándor	Sipka,	MD,	PhD,	DSc	
Dr.	Zoltán	Pós,	PhD		
The	Examination	took	place	at	Department	of	Molecular	Biology	and	Biochemistry,	Faculty	of	Medicine,	
University	of	Debrecen	at	11	a.m.,	10th	of	July	2017		
	
Head	of	the	Defense	Committee:		 	 Prof.		Gábor	Szabó,	MD,	PhD,	DSc		
Reviewers:		 	 	 	 	 Prof.	Attila	Tóth,	PhD,	DSc		
Dr.	Silvia	Brunelli,	PhD		
Members	of	the	Defense	Committee:		 Prof.	Péter	Nagy,	MD,	PhD,	DSc		
Dr.	Zoltán	Pós,	PhD	
The	PhD	Defense	will	take	place	at	the	Lecture	Hall	of	Department	of	Pathology,	Faculty	of	Medicine,	
University	of	Debrecen,	at	11	a.m.,	14th	of	December	2017.	
	
	
	
	 3	
Introduction	
	
1.	Inflammation	
	
• Overview		
	
The	 four	 principal	 signs	 of	 inflammation	 are	 known	 as	 "Celsus	 tetrad":	 calor	 (heat),	 dolor	 (pain),	
tumor	 (swelling)	 and	 rubor	 (redness).	 However,	 the	 past	 decades	 offered	 greater	 insights	 on	 how	
inflammation	 is	 initiated,	 sustained	 and	 resolved.	 Inflammation	 is	 a	 physiological	 protective	 response,	
initiated	after	infection	or	injury.	Inflammatory	responses	taking	place	either	locally	or	systemically	aim	to	
eliminate	 threats,	 and	 to	 promote	 tissue	 repair	 and	 healing.	 In	 the	 case	 of	 infection,	 immune	memory	
needs	to	be	established	in	order	for	the	host	to	mount	a	faster	response	upon	secondary	encounters.	Thus,	
in	general	a	controlled	inflammatory	response	is	beneficial	against	infection,	but	it	can	become	harmful,	if	
dysregulated.	Many	types	of	inflammation-related	responses	are	only	known	in	pathological	conditions	but	
the	 physiological	 initiation	 counterpart,	 which	 is	 an	 important	 piece	 of	 the	 puzzle,	 is	 not	 known.	 Since	
inflammation	seemingly	evolved	as	a	response	for	restoring	homeostasis,	elucidating	the	mechanisms	that	
drive	physiological	inflammation	will	help	to	understand	the	dysregulated	inflammatory	processes	that	lead	
to	systemic	chronic	inflammatory	states.	
Through	 evolution	 vertebrates	 have	 developed	 a	 complicated	 recognition	 system	 in	 order	 to	
effectively	guard	themselves,	which	involves	both	fast	acting	innate	and	slowly	activated	adaptive	immune	
responses	by	delivering	plasma	and	leukocytes	to	the	site	of	infection	or	injury.	Many	cell	types	contribute	
to	these	immune	responses	but	in	this	dissertation,	we	will	focus	on	the	different	types	of	macrophages	and	
will	try	to	dissect	their	roles.	Innate	immune	cells	such	as	monocytes	and	macrophages	are	able	to	detect	
specific	molecules	through	their	pattern	recognition	receptors	(PRRs)	and	thus	trigger	the	initiation	events	
of	 inflammation.	 This	 infection	 recognition	 response	 has	 been	 characterized	 best	 for	 bacterial	 infections	
through	specialized	receptors	called	Toll-like	receptors	(TLRs)	and	NOD	(nucleotide-binding	oligomerization-
domain	protein)-like	receptors	(NLRs).	Tissue-resident	macrophages	and	mast	cells,	mediate	the	 initiation	
of	 the	 inflammatory	 response	 by	 producing	 inflammatory	 mediators	 such	 as	 chemokines,	 cytokines,	
vasoactive	amines,	eicosanoids	and	products	of	proteolytic	cascades.	These	mediators	help	plasma	proteins	
and	leukocytes	(mainly	neutrophils)	to	enter	the	tissues	at	the	site	of	infection	(or	injury)	while	at	the	same	
time	 prevent	 the	 exit	 of	 erythrocytes.	 Neutrophils	 become	 activated	 either	 by	 direct	 contact	 with	
pathogens	 or	 through	 the	 actions	 of	 cytokines	 secreted	 by	 tissue-resident	 cells,	 and	 kill	 the	 invading	
pathogens	by	releasing	the	contents	of	 their	granules	 (reactive	oxygen	species,	 reactive	nitrogen	species,	
proteinase,	 cathepsin	 and	 elastase).	 However,	 the	 actions	 of	 neutrophils	 do	 not	 discriminate	 between	
pathogen	and	host	 targets.	Whereas	 sustained	 inflammation	 is	essential	 to	battling	pathogens,	excessive	
inflammation	can	 lead	to	severe	tissue	damage.	Therefore,	 immune	responses,	physiologically,	are	tightly	
regulated	and	in	many	cases	self-restricted	via	negative	feedback	signaling	loops.	For	example,	the	switch	in	
lipid	mediators	 (from	 prostaglandins	 to	 lipoxins)	 is	 critical	 for	 the	 resolution	 of	 inflammation.	 Resolvins,	
protectins,	 transforming	 growth	 factor-β	 and	 growth	 factors,	 produced	 by	 infiltrating	macrophages,	 also	
have	a	crucial	role	in	the	resolution	of	inflammation	and	the	initiation	of	tissue	repair.	
As	mentioned	above	a	large	number	of	mediators	are	produced	during	the	inflammatory	response.	
For	simplicity,	they	are	classified	as	inducers,	which	act	as	signals	to	initiate	the	inflammatory	response,	and	
mediators	 that	 act	 as	 effectors	 of	 inflammation.	 Inducers	 can	 activate	 specialized	 sensors,	which	 in	 turn	
lead	 to	 the	 production	 of	 specific	 sets	 of	 mediators.	 Thus,	 inflammation	 consists	 of	 inducers,	 sensors,	
mediators	 and	 effectors,	 expressed	 and	 produced	 mainly	 by	 macrophages,	 thus	 defining	 the	 type	 of	
inflammatory	response.	In	the	following	sections,	these	components	are	discussed.	
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• Classical	and	alternative	polarization	of	macrophages	
	
	 Macrophages	 are	 cells	 that	 are	 characterized	 by	 extended	 flexibility	 and	 plasticity.	 Under	 various	
signals	 such	microbial	 products	 or	 damaged	 cells	 macrophage	 undergo	 either	 classical	M1	 activation	 or	
alternative	M2	activation.	M1	polarized	macrophages	in	vitro	are	activated	by	various	TLR	ligands	and	IFN-g,	
while	M2	polarized	macrophages	are	activated	by	 Interleukin-4	and	Interleukin-13	(IL-4/IL-13).	 In	general,	
M1	macrophages	 express	 high	 levels	 of	 pro-inflammatory	 cytokines	 and	 reactive	 nitrogen	 intermediates	
(iNOS)	and	thus	act	strongly	against	microbes.	On	the	other	hand,	 the	M2	phenotype	 is	characterized	by	
anti-parasitic	 activity,	 tissue	 remodeling,	 wound	 healing	 and	 tumor	 sustained	 progression	 through	 its	
immunoregulatory	 activity	 (Tumor	 Associated	 Macrophages).	 In	 addition,	 M2	 macrophages	 have	 high	
expression	 of	 scavenging	 molecules,	 produce	 L-ornithine	 through	 the	 arginase	 pathway	 and	 are	
distinguished	by	low	levels	of	IL-12	and	high	levels	of	IL-10.	Furthermore,	M1	versus	M2	macrophages	have	
different	chemokine	expression	profiles.	
Transcription	factors,	posttranscriptional	regulators,	sensors	and	signaling	molecules	are	involved	in	
regulating	 macrophage	 activity.	 For	 example,	 the	 balance	 between	 activation	 of	 Signal	 transducer	 and	
activator	 of	 transcription-1	 (STAT1)	 and	 STAT3/STAT6	 fine-tunes	 macrophage	 activity	 and	 subsequently	
polarization.	 In	 this	 context,	 NF-κB	 and	 STAT1	 activation	 promotes	 M1	 macrophage	 polarization,	 while	
STAT3	and	STAT6	activation	results	in	M2	macrophage	polarization,	which	is	associated	with	resolution	of	
inflammation.	 Similarly,	 the	 nuclear	 receptors	 PPARg	 and	 PPARd	 regulate	 various	 aspects	 of	 M2	
macrophage	activation	and	oxidative	metabolism.	Krüppel-like	factors	such	as	KLF4	and	KLF2	promote	M2	
macrophage	 functions	 through	 STAT6	 and	 by	 suppressing	 the	 NF-κB/HIF-1α–dependent	 pathway.	 In	 the	
same	 context,	 c-Myc	 gets	 activated	 by	 IL-4	 and	 regulates	 M2-associated	 genes	 such	 as	 Scarb1,	 Alox15,	
Mrc1,	 STAT6	 and	 PPARg.	 Epigenetically	 IL-4	 also	 induces	 the	 Jmjd3-IRF4	 axis	 to	 inhibit	 M1	 polarization	
through	IRF5	and	thus	promote	M2	polarizing	conditions.	Akt	kinases	and	noncoding	RNAs	such	as	mir155	
and	mir146	have	also	been	shown	to	regulate	macrophage	polarization.	
The	 general	 dogma	 is	 that	 under	 conditions	 such	 as	 allergy,	 cancer	 and	 parasite	 infections	 the	
functional	macrophages	phenotypes	 in	 vivo	 are	 similar	 to	 those	of	 canonical	M1/M2	polarized	 states,	 as	
defined	 in	vitro.	 Importantly,	a	key	concept	 is	 that	macrophage	polarization	and	thus	 its	activation	status	
has	been	linked	to	pathology.	M1	polarized	macrophages	have	been	implicated	in	initiating	and	sustaining	
inflammation,	while	the	M2	polarized	phenotype	has	been	associated	with	the	resolution	of	inflammation,	
and	if	dysregulated,	with	chronic	inflammation.	However,	macrophage	plasticity	has	been	mainly	addressed	
in	 in	 vitro	 systems	 that	 do	 not	 consider	 the	 complexity	 that	 the	macro-	 and	microenvironment	 provide	
within	 the	 tissue.	 Thus,	 considering	 the	 observations	 from	 recent	 in	 vivo	 studies,	 the	 general	 dogma	 is	
currently	under	revision.	
	
• Resolution	of	Inflammation	
	
Arising	from	these	advances,	it	has	been	proposed	that	most	of	the	chronic	inflammatory	diseases	
may	be	caused	not	only	by	ongoing	pro-inflammatory	processes,	but	also	by	dysregulated	resolution,	and	
thus	 therapeutic	 intervention	 might	 be	 very	 effective	 if	 focused	 in	 guiding	 inflammation	 towards	 pro-
resolution.	 In	 general,	 resolution	 of	 inflammation	 involves	 the	 clearance	 of	 infiltrated	 inflammatory	 cells	
and	restoration	to	homeostasis.	This	process	 is	not	considered	passive	but	rather	tightly	regulated	events	
need	 to	 occur.	 Initially,	 the	 inflammatory	 cues	 (CC-cytokines,	 CXC	 chemokines	 etc.)	 that	 triggered	
inflammation	are	eliminated,	 thus	preventing	 further	 inflammatory	cell	 infiltration	and	edema	formation.	
At	 the	 same	 time	 synthesis	 of	 pro-inflammatory	mediators	 is	 inhibited.	Next,	 immune	 cells	 of	 the	 initial	
response	such	as	neutrophils	and	eosinophils	are	cleared	from	the	 inflamed	tissue	by	 local	apoptosis	and	
subsequent	uptake	by	recruited	monocyte-derived	macrophages	in	a	process	called	efferocytosis.	Once	this	
process	is	complete,	macrophages	either	undergo	local	apoptosis	or	exit	the	tissue	by	lymphatic	drainage.	
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However,	it	has	been	recently	proposed	that	there	is	a	third	phase	called	post-resolution.	During	this	phase,	
there	is	a	second	influx	of	myeloid	cells	(including	CD11B+CD49d+CD115+MHCII+	myeloid-derived	suppressor	
cells,	 F4/80lowMHCII+CD11c+	 DCs,	 and	 F4/80midCD11BhiCD11c−)	 into	 the	 tissue	 and	 remain	 for	 weeks	 to	
regulate	 either	 the	 adaptive	 response	 or	 the	 magnitude	 and	 duration	 of	 a	 subsequent	 acute	 innate	
response.	 This	 suggests	 that	 resolution	 is	 connecting	 innate	 and	 adaptive	 immunity,	 and	 chronic	
inflammation	could	be	explained	as	incomplete	resolution	of	the	initial	acute	inflammatory	response	which	
in	turn	fails	to	initiate	an	appropriate	adaptive	immune	response.	
As	already	mentioned	above,	to	initiate	the	resolution	process,	certain	events	need	to	take	place,	(1)	
removal	 of	 stimuli,	 (2)	 dampening	 of	 pro-inflammatory	 signaling,	 and	 (3)	 clearance	 of	 pro-inflammatory	
mediators.	 The	 importance	of	antigen	clearance	 is	demonstrated	 in	 immunodeficiency	disorders,	 such	as	
chronic	granulomatous	disease,	and	autoimmune	diseases,	such	as	rheumatoid	arthritis	and	systemic	lupus	
erythematosus,	that	are	driven	by	persistent	endogenous	antigens.	Following	stimulus	removal,	receptors	
and	their	signaling	pathways	that	triggered	the	release	of	pro-inflammatory	mediators	must	be	turned	off	in	
order	 to	 prevent	 excessive	 damage	 from	 an	 ongoing	 pro-inflammatory	 state.	 An	 example	 of	 a	 failure	 in	
dampening	of	pro-inflammatory	 signaling	 is	 sepsis.	During	 this	 condition,	 large	 amounts	of	 cytokines	 are	
still	 present	despite	negative	bacterial	blood	cultures.	A	number	of	 inflammation	 regulatory	mechanisms	
have	been	described,	such	as	through	miRNAs	(i.e.	miR-146,	miR-21),	ARE-binding	proteins	(tristetraprolin	
B-related	factor	1,	KH-type	splicing	regulatory	protein	and	ARE	RNA-binding	protein	1),	leucine-	rich	repeat-
containing	protein	33	(LRRC33)	or	lipid	mediators	such	as	prostaglandin	E2	(PGE2),	that	inhibit	IFNg	and	TLR	
signaling	 and	 subsequently	 NFkB	 activation.	 Following	 removal	 of	 the	 injurious	 agent	 and	 turning	 off	
signaling	 pathways,	 the	 levels	 of	 cytokines,	 chemokines,	 eicosanoids,	 cell	 adhesion	molecules	 and	 other	
inflammatory	mediators	 need	 to	 be	 catabolized	 and	 return	 back	 to	 their	 pre-inflamed	 state.	 These	 data	
indicate	that	there	are	various	routes	to	resolution;	thus,	it	is	unlikely	that	one	single	intervention	will	be	a	
panacea	for	all	inflammatory	diseases.		
The	 development	 and	 application	 of	 pro-resolution	 therapeutic	 strategies	 to	 treat	 chronic	
inflammation	may	transform	the	management	of	some	of	the	oldest	and	most	frequent	human	illnesses.	By	
approaching	 such	 diverse	 disease	 states	 from	 the	 opposite	 perspective;	 asking	 not	 how	 to	 suppress	 the	
initiation	of	 inflammation,	but	how	 to	enhance	clearance	of	 the	 triggering	 stimuli,	we	will	hopefully	gain	
new	insights	into	both	the	origin	of	chronic	inflammation	and	pharmaceutical	therapeutics	of	tackle	them.		
	
2.	Tissue	injury	and	regeneration	
	
• Overview	
	
Tissue	 repair	 and	 regeneration	 are	 vital	 for	 survival.	 Repair,	 also	 referred	 to	 as	 healing,	 is	 the	
restoration	 of	 tissue	 structure	 and	 function	 following	 an	 injury.	 Infection,	 toxic	 or	mechanical	 injury	 can	
severely	impact	tissue	integrity.	Repair	of	injured	tissues	occurs	by	two	types	of	processes:	proliferation	of	
uninjured	cells	and	maturation	of	tissue	stem	cells.	However,	some	tissues	are	able	to	replace	the	damaged	
components	and	essentially	return	to	a	normal	state	in	a	process	called	regeneration.	Regeneration	occurs	
by	proliferation	of	 cells	 that	 survive	 the	 injury	and	 retain	 the	capacity	 to	proliferate.	For	example,	 in	 the	
rapidly	dividing	epithelia	of	 the	skin	and	 intestines,	 liver	and	skeletal	muscle.	However,	mammals	have	a	
limited	capacity	to	regenerate	damaged	tissues	and	organs,	and	only	some	parts	of	most	tissues	are	able	to	
fully	regenerate.	Notably	skeletal	muscle,	skin	and	liver	have	been	used	as	reference	tissues	for	the	study	of	
tissue	regeneration.		
Three	 types	 of	 tissues	 exist:	 labile,	 stable	 and	 permanent.	 (1)	 Cells	 from	 labile	 tissues	 are	
continuously	being	 lost	and	replaced	by	maturation	from	tissue	stem	cells	and	by	proliferation	of	mature	
cells.	These	cells	include	the	hematopoietic	cells	in	the	bone	marrow,	the	majority	of	surface	epithelia	(skin,	
oral	cavity,	vagina,	and	cervix),	the	cuboidal	epithelia	of	the	ducts	draining	exocrine	organs	(salivary	glands,	
	 6	
pancreas,	biliary	 tract),	 the	columnar	epithelium	of	 the	gastrointestinal	 tract,	uterus,	and	 fallopian	tubes;	
and	the	transitional	epithelium	of	the	urinary	tract.	These	tissues	can	readily	regenerate	after	injury	as	long	
as	the	pool	of	stem	cells	is	preserved	and	provided	the	underlying	basement	membrane	is	intact.	(2)	Cells	
from	 stable	 tissues	 are	 quiescent	 (in	 the	G0	 stage	 of	 the	 cell	 cycle)	 and	 have	 only	minimal	 proliferative	
activity	in	their	normal	state.	These	cells	can	proliferate	in	response	to	loss	of	tissue	mass	or	due	to	injury.	
Stable	cells	 constitute	 the	parenchyma	of	most	 solid	 tissues,	 such	as	 liver,	 kidney,	and	pancreas	but	also	
endothelial	cells,	fibroblasts,	and	smooth	muscle	cells.	Stable	tissues	have	a	limited	capacity	to	regenerate	
after	injury	except	from	liver.	Mechanisms	underlying	this	response	are	not	understood,	but	likely	involve	
local	production	of	growth	factors	and	interactions	of	cells	with	the	ECM.	(3)	Cells	from	permanent	tissues	
are	 considered	 to	 be	 terminally	 differentiated	 and	 non-proliferative	 in	 postnatal	 life.	 The	 majority	 of	
neurons	and	cardiac	muscle	cells	belong	to	this	category.	Thus,	 injury	to	the	brain	or	heart	 is	 irreversible	
and	 results	 in	 a	 scar,	 because	 neurons	 and	 cardiac	 myocytes	 cannot	 regenerate.	 Limited	 stem	 cell	
replication	and	differentiation	occur	in	some	areas	of	the	adult	brain,	and	there	is	some	evidence	that	heart	
muscle	cells	may	proliferate	after	myocardial	necrosis.	Nevertheless,	whatever	proliferative	capacity	may	
exist	 in	 these	 tissues,	 it	 is	 insufficient	 to	 produce	 tissue	 regeneration	 after	 injury.	 Thus,	 in	 permanent	
tissues,	repair	is	typically	dominated	by	scar	formation.	Skeletal	muscle	is	usually	classified	as	a	permanent	
tissue,	but	satellite	cells	attached	to	the	endomysial	sheath	provide	regenerative	capacity	to	muscle.		
The	repair	process	consists	of	inflammation	and	proliferation	of	satellite	and	other	cells.	Wounding	
causes	the	rapid	activation	of	coagulation	pathways,	which	results	in	the	formation	of	a	that	clot	contains	
fibrin,	fibronectin,	and	complement	proteins.	The	clot	serves	to	act	as	a	scaffold	for	migrating	cells,	which	
are	 attracted	 by	 growth	 factors,	 cytokines,	 and	 chemokines	 released	 into	 the	 area.	 Within	 24	 hours,	
neutrophils	are	seen,	migrating	toward	the	fibrin	clot.	They	release	proteolytic	enzymes	that	begin	to	clear	
the	debris	and	within	48	hours,	satellite	cells	start	 to	proliferate.	By	day	3,	neutrophils	have	been	 largely	
replaced	by	macrophages	which	are	key	cellular	constituents	of	tissue	repair,	clearing	extracellular	debris,	
fibrin,	and	promoting	angiogenesis	and	ECM	deposition.	By	day	5,	neovascularization	reaches	its	peak	but	
these	new	vessels	are	leaky,	allowing	the	passage	of	plasma	proteins	and	fluid	into	the	extravascular	space.	
In	addition,	migration	of	fibroblasts	to	the	site	of	 injury	 is	driven	by	chemokines,	TNFa,	PDGF,	TGF-β,	and	
FGF	and	their	subsequent	proliferation	is	triggered	by	multiple	growth	factors,	including	PDGF,	EGF,	TGF-β,	
and	FGF,	and	the	cytokines	IL-1b	and	TNFa.	During	the	second	week,	the	leukocyte	 infiltrate,	edema,	and	
increased	vascularity	are	substantially	diminished.		
	
• Animal	models	and	morphological	characteristics	of	acute	muscle	injury	and	repair	
	
Muscle	regeneration	is	a	highly	efficient	process	that	if	compromised	can	lead	to	several	pathologies	
such	 as	 myopathies.	 Therefore,	 understanding	 the	 processes	 of	 tissue	 homeostasis,	 maintenance	 and	
regeneration	 is	 crucial	 to	 devise	 novel	 therapeutics.	 In	 order	 to	 study	 such	 processes,	 the	 use	 of	
reproducible	and	tightly	controlled	experimental	models	of	muscle	injury	and	repair	are	needed.	The	most	
commonly	used	models	of	acute	muscle	injury	and	repair	are	mechanical	 injury	(freeze	injury,	 irradiation,	
crush,	denervation	and	 transplantation),	myotoxins	 (notexin	and	cardiotoxin)	and	chemical	agent	 (BaCl2).	
Although	 the	 regeneration	process	 restores	 the	muscle	 tissue	 in	all	 these	models,	 the	pathophysiological	
processes	involved,	vary	depending	on	the	model	(differences	regeneration	kinetics,	re-vascularization,	and	
satellite	 cell	 behavior).	 To	 begin	with,	 CTX,	NTX	 and	BaCl2	 induce	 severe	 necrosis	 of	 the	 tissue,	 followed	
immediately	 by	 neutrophil	 and	 macrophage	 infiltration	 that	 leads	 to	 synchronous	 regeneration.	 Next	
myoblasts	appear	and	start	fusing	to	form	larger	structures	(myotubes).	The	tissue	regenerates	ad	integrum	
within	 a	 relatively	 short	 period	 (8	 days	 in	 young	 adult	 mice).	 During	 the	 freeze-injury	model	 and	 other	
mechanical	 injury	 models,	 asynchronous	 regeneration	 takes	 place	 instead.	 In	 these	 models,	 there	 are	
distinct	 regeneration	 foci	 in	which	 all	 the	 different	 regeneration	 steps	 are	 present	 at	 the	 same	 time.	 In	
addition,	although	the	 inflammation	kinetics	appear	to	be	 identical	 for	all	models;	differences	 in	cytokine	
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production	exist.	For	example,	after	CTX	injury,	 inflammatory	cytokine	expression	returned	to	basal	 levels	
when	the	muscle	was	morphologically	regenerated,	while	in	the	other	models,	the	expression	of	cytokines	
was	never	back	to	basal	levels.	This	suggests	that	there	is	still	ongoing	inflammation	in	these	models	despite	
the	 normal	 appearance	 of	 the	 regenerated	 muscles.	 Skeletal	 muscles	 are	 comprised	 largely	 of	
differentiated	myofibres	that	have	 irreversibly	 left	the	cell	cycle.	Following	 injury,	satellite	cells	which	are	
mostly	quiescent,	re-enter	the	cell	cycle	and	generate	myoblasts	that	will	participate	in	muscle	restoration.			
Skeletal	muscle	 regeneration	has	emerged	as	an	 important	paradigm	to	study	 the	role	of	 satellite	
and	stromal	cells	 following	 tissue	 injury.	Satellite	cells	are	vital	 to	muscle	 regeneration	but	 their	 function	
involves	interactions	with	the	macro-	and	micro-environment	including	interactions	with	macrophages	and	
fibroblasts.	The	satellite	cell	microenvironment	changes	based	on	the	injury	model.	For	example,	after	NTX	
or	freeze	injury,	severe	vascular	lesions	and	granulomas	(multinucleated	giant	cells)	appear	which	explains	
the	differences	in	regeneration	kinetics.	In	all	of	the	injury	models,	loss	of	satellite	cells	can	be	seen,	but	it	
also	varies	based	on	the	severity	of	the	injury.	Different	volumes	of	toxins	can	have	an	impact	on	the	area	
of	the	injured	muscle,	with	higher	volumes	leading	to	higher	satellite	cell	death	and	a	delay	in	their	division.	
In	 general,	 in	 the	NTX,	 CTX	 and	 BaCl2	models	 almost	 60%	of	 the	 satellite	 cells	 survive	while	with	 freeze	
injury	 about	 95%	 of	 satellite	 cells	 are	 lost.	 However,	 3-4	 weeks	month	 post-injury,	 a	 higher	 number	 of	
satellite	cells	can	be	seen	in	all	models	while	they	continue	to	cycle	at	different	rates	based	on	the	model.	
Lastly	 re-vascularization	 is	 an	 important	 process	 during	 skeletal	muscle	 regeneration	 since	 it	 can	 impact	
both	 the	 distribution	 of	 recruited	 inflammatory	 cells	 and	 regeneration-related	 factors	 (growth	 factors,	
cytokines,	chemokines)	but	also	the	communication	between	endothelial	and	satellite	cells.	The	mechanical	
injuries	result	in	a	more	severe	destruction	of	the	vasculature	compared	to	the	other	models	prolonging	the	
regeneration	process.	Since	85%	of	satellite	cells	are	located	close	to	blood	vessels,	it	can	have	an	impact	on	
satellite	cell	oxygen	availability,	which	in	turn	could	affect	their	proliferation	and	differentiation.	
Muscle	regeneration	following	any	acute	injury	is	a	very	efficient	and	reliable	process	to	provide	fast	
recovery.	On	the	other	hand,	recovering	from	a	chronic	related	damage	is	not	a	very	efficient	process	due	
to	the	lack	of	a	system	adapted	to	these	types	of	injuries.	As	a	result,	immune	responses	related	to	muscle	
regeneration	 get	 dysregulated,	 cause	 muscle	 fibrosis	 and	 lead	 to	 impaired	 regeneration.	 Such	 muscle	
regeneration	 defects	 can	 be	 seen	 for	 example	 in	 Duchenne	 muscular	 dystrophy	 (DMD).	 In	 this	 DMD	
disorder	the	cell	membrane	 is	weak,	causing	chronic	damage,	repeated	cycles	of	regeneration,	 leading	to	
chronic	 inflammation	 that	 exacerbates	 the	 pathology.	 Importantly,	 it’s	 been	 shown	 that	 chronic	 injury	
alters	 the	macrophage	phenotypes	 responsible	 for	proper	muscle	 regeneration	 following	an	acute	 injury,	
which	 in	 turn	 disrupt	 the	 normal	 regulation	 of	 connective	 tissue	 deposition.	 Furthermore,	 the	 repair	
macrophages	 associated	 with	 dystrophy	 seem	 to	 become	 highly	 fibrogenic	 (by	 enhancing	 arginase	 1	
activity)	and	exacerbate	the	fibrosis-related	pathology.	However,	despite	the	critical	role	of	macrophages	in	
muscular	dystrophy,	the	mechanisms	that	control	the	phenotypic	transition	of	macrophages	in	chronically	
injured	muscle	remain	elusive.	
	
3.	Myeloid	cell	regulation	of	skeletal	muscle	regeneration	
• Overview	
Many	cell	types	are	taking	part	in	the	regeneration	process	but	resident	and	recruited	macrophages,	
due	 to	 their	 plasticity,	 play	 a	 vital	 role	 in	 all	 stages	of	 repair	 and	 fibrosis.	 In	 fact,	 a	 recent	 cell-depletion	
study	revealed	that	macrophages	are	critically	required	for	full	limb	regeneration	in	adult	salamanders,	but	
surprisingly,	wound	closure	following	limb	amputation	is	much	less	dependent	on	macrophages.	A	similar	
macrophage-depletion	 strategy	 in	 mice	 determined	 that	 macrophages	 provide	 critical	 signals	 that	 drive	
angiogenesis	and	tissue	regeneration	after	myocardial	 infarction	 in	neonatal	hearts,	which	are	capable	of	
complete	regeneration.	In	the	context	of	muscle	regeneration	macrophage	depletion	completely	abolishes	
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the	ability	of	skeletal	muscle	to	regenerate.	Importantly,	macrophages	are	also	critical	to	the	clearance	of	
senescent	cells	and	owing	to	their	role	in	controlling	the	initiation,	maintenance	and	resolution	of	wound-
healing	responses	in	different	organ	systems,	by	creating	a	regeneration-permissive	environment,	they	are	
considered	major	therapeutic	targets.		
Different	 macrophage	 populations	 reside	 in	 many	 tissues	 and	 usually	 derived	 from	 the	 yolk	 sac	
during	the	early	stages	of	embryogenesis.	However,	some	derive	from	later	stages	of	embryogenesis	such	
as	 from	 fetal	 liver	 and	 hematopoietic	 stem	 cells.	 The	 tissue	 resident	macrophages	 are	 important	 during	
development	but	also	 for	normal	 tissue	homeostasis	by	producing	growth	and	 trophic	 factors	 to	support	
neighboring	 tissues.	 Following	 acute	 injury,	 a	 large	 number	 of	 inflammatory	 Ly6Chigh	 monocytes	 are	
recruited	 from	 the	 bone	 marrow	 and	 circulation,	 via	 gradients	 of	 chemokines	 and	 adhesion	 molecules.	
These	macrophage	precursors	far	exceed	the	numbers	of	tissue	resident	macrophages,	but	both	proliferate	
and	 undergo	 distinct	 phenotypic	 changes	 in	 response	 to	 the	 local	 tissue	microenvironment	milieu.	 Early	
studies	 on	 macrophage	 contribution	 to	 tissue	 repair	 was	 focused	 on	 their	 role	 as	 scavenger	 cells	 that	
uptake	cellular	debris,	pathogens,	neutrophils	and	other	apoptotic	cells	following	tissue	injury.	However,	a	
number	 of	 recent	 studies	 have	 demonstrated	 a	more	 complex,	 specialized	 and	 critically	 timed	 states	 of	
monocytes	and	macrophages	during	repair,	regeneration	and	fibrosis.	Data	from	these	studies	support	one	
of	 macrophage’s	 hallmark	 characteristic	 which	 is	 plasticity.	 It	 appears	 that	 different	 macrophage	
phenotypes	 could	 be	 tissue-,	 stimulus-	 and	 phase-specific.	 A	 tissue	 such	 as	 skeletal	 muscle	 can	 cause	
distinct	populations	of	 immune	cells	 to	appear	depending	on	disease	etiology.	 For	example,	 in	a	 skeletal	
muscle	 regeneration	paradigm,	 inflammatory	monocytes	 infiltrating	 the	 injured	muscle	switch	to	a	 repair	
macrophage	 phenotype	 to	 support	myogenesis	 in	 an	 AMPKa1	 (5ʹ-AMP-activated	 protein	 kinase	 catalytic	
subunit	α1)	dependent	manner.	On	the	other	hand,	dystrophic	muscle	and	increased	pathological	fibrosis	
has	also	been	associated	with	distinct	macrophage	populations.	
During	the	initial	cellular	response	following	the	injury,	chemokines,	matrix	metalloproteinases	and	
various	inflammatory	molecules	are	produced	by	the	infiltrating	macrophages.	This	is	supported	by	the	fact	
that	 if	 you	 deplete	 macrophages	 early	 after	 the	 injury,	 the	 inflammatory	 response	 will	 greatly	 be	
diminished.	However,	 as	mentioned	 above,	 depletion	 of	macrophages	will	 lead	 to	 impaired	 clearance	 of	
necrotic	debris	 and	 subsequently	 to	 less	 efficient	 regeneration.	 Following	 the	 initial	 inflammatory	phase,	
macrophages	acquire	a	pro-resolution	and	tissue	repair	phenotype	which	is	characterized	by	the	production	
of	several	growth	factors,	such	as	members	of	the	TGF-	β	superfamily	including	transforming	growth	factor	
β1	 (TGF-β1)	 and	 other	 growth	 factors	 such	 as	 platelet-derived	 growth	 factor	 (PDGF),	 insulin-like	 growth	
factor	1	(IGF-1),	and	vascular	endothelial	growth	factor	α	(VEGF-α).	These	secreted	factors	seem	to	promote	
satellite	and	fibroblast	cell	proliferation,	differentiation	and	neovasculature	development.	This	macrophage	
subtype	 can	 also	 facilitate	 the	 synthesis	 of	 extracellular-matrix	 components,	 respond	 and	 secrete	
interleukin-10	(IL-10)	and	other	inflammation	inhibitory	mediators,	such	as	programmed	cell	death	ligands	
1	and	2.	In	addition,	the	current	notion	is	that	monocytes	and	macrophages	respond	differently	to	similar	
inflammatory	signals	and	according	to	the	inflammation	phase,	hence	showing	that	diverse	phenotypes	are	
neither	 M1	 (pro-inflammatory)	 nor	 M2	 (anti-inflammatory).	 In	 conclusion,	 different	 macrophage	
phenotypes	seem	to	play	crucial	and	unique	roles	at	each	stage	of	the	regeneration	process	and	identifying	
the	 regulators	 of	 the	 phenotypic	 shift	 is	 critical	 to	 devise	 targeted	 muscle-inflammation	 related	
therapeutics.	
• Inflammatory	monocyte	to	repair	macrophage	transition	
Mechanisms	 of	 infection-induced	 inflammation	 are	 understood	 far	 better	 than	 those	 of	 other	
inflammatory	processes	such	as	injury	related.	Although	infection-induced	inflammation	is	vital,	it	might	be	
a	special	case	since	 it	 is	clear	now	that	 injury-related	physiological	 inflammation	does	not	seem	to	fit	the	
classic	pattern	of	inflammation.	The	reason	behind	this	is	that	cell	states	are	distinct	while	tissue	states	are	
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graded.	For	example,	 tissues	might	contain	cells	 that	are	dead,	malfunctioned	or	healthy,	all	at	 the	same	
time.	 Thus,	 at	 normal	 conditions,	 the	 tissues	 remain	 at	 homeostatic	 state,	 usually	 by	 the	 help	 of	 tissue-
resident	macrophages.	However,	when	tissues	undergo	stress	due	to	an	acute	injury	for	example,	they	can	
malfunction	if	the	insult	is	excessive.	In	this	case	additional	recruited	macrophages	are	needed	to	help	the	
tissue	overcome	these	issues.	A	particularly	interesting	and	important	aspect	of	regeneration	is	the	invasion	
and	 conversion	 of	 circulating	 inflammatory	 monocytes	 into	 inflammatory	 macrophages	 (MFs)	 and	 then	
conversion	 into	repair-type	ones.	Acute	muscle	 injury	causes	the	recruitment	of	monocytes/macrophages	
into	the	damaged	area	of	the	muscle	and	this	invasion	peaks	within	the	first	2	days	after	the	injury.	In	the	
absence	of	macrophages,	muscle	 regeneration	 is	 severely	 impaired,	highlighting	 the	 importance	of	 these	
cells	in	the	regeneration	process.	The	roles	of	these	immune	cells	in	response	to	injury	are	to	(1)	confine	the	
damage,	(2)	clear	the	necrotic	debris	through	phagocytosis,	and	(3)	repair	the	damage.	There	are	multiple	
lines	 of	 evidence	 to	 suggest	 that	macrophages	 instruct	 satellite	 cells	 to	 proliferate	 and	 differentiate,	 by	
secreting	cytokines,	growth	factors	and	other	molecules	that	regulate	the	satellite	cell	pool,	 including	our	
recent	 findings	 that	 macrophage-secreted	 growth	 and	 differentiation	 factor	 3	 contributes	 to	 myoblast	
fusion.	This	highly	dynamic	process	is	characterized	by	an	in-situ	transition	of	infiltrating	monocytes	from	an	
inflammatory	(Ly6ChighF4/80low)	to	a	repair	(Ly6ClowF4/80high)	macrophage	phenotype,	which	appears	to	be	
indispensable	for	proper	muscle	regeneration.		
	 Distinct	 inflammatory	 and	 repair	macrophage	 phenotypes	 have	 also	 been	 reported	 in	 spinal-cord	
injury	 models.	 In	 these	 models,	 inflammatory	 monocytes	 (Ly6ChighCX3CR1low)	 enter	 the	 injury	 sites	 in	 a	
CCL2-depentent	 manner,	 whereas	 repair	 macrophages	 (Ly6ClowCX3CR1high)	 movement	 is	 controlled	 by	
adhesion	proteins	 (VCAM-1,	VLA-4)	and	endothelial-cell-surface	enzymes	 that	are	 implicated	 in	 leukocyte	
extravasation.	 Thus,	 it	 appears	 that	 the	 guided	 trafficking	 of	 infiltrating	 monocytes	 and	 macrophages	
towards	the	injury	site	provides	crucial	signals	to	shape	their	unique	functions.	Similar	studies	performed	in	
other	 tissues,	 revealed	 regulators	 (such	 as	 regenerating	 islet-derived	 3β	 and	 C19orf10)	 of	 macrophage	
movement	 to	 injured	 cardiac	 muscles.	 These	 factors	 are	 involved	 in	 removal	 of	 neutrophils	 by	 repair	
macrophages,	 thus	 protecting	 these	 tissues	 from	 extensive	 damage	 and	 cardiac	 rupture	 following	
myocardial	infarction.	Recent	studies	also	highlight	that	a	single	population	of	monocytes	can	acquire	both	
pro-inflammatory	and	pro-repair	phenotypes,	suggesting	that	an	 in	situ	phenotypic	transition,	rather	than	
recruitment	 of	 a	 different	 pro-reparative	 Ly6C	 subset,	 takes	 place.	 For	 example,	 removing	 the	 Ly6C-	
monocytes	 populations	 from	 the	 circulation	 does	 not	 affect	 the	 presence	 of	 repair	macrophages	 or	 the	
outcome	of	muscle	regeneration.	In	addition,	activin-a	(supports	oligodendrocyte	differentiation)	has	been	
identified	as	a	repair	macrophage-derived	mediator	participating	in	the	phenotypic	shift	of	microglia	from	a	
pro-inflammatory	to	a	repair	phenotype.	Similar	findings	in	liver	injury	models	suggest	that	cytokines	such	
as	 IL-4,	 IL-10,	and	the	uptake	of	dead	cells	through	phagocytosis	regulate	the	conversion	of	 inflammatory	
monocytes	into	repair	macrophages.	In	addition,	in	these	models	Wnt	signaling	appears	to	be	an	important	
pathway	in	macrophages,	which	regulates	regeneration	by	driving	the	differentiation	of	progenitor	cells	to	
hepatocytes.	In	a	lung	injury	model	(acute	pathogen-induced	injury),	it	has	been	shown	that	IL-17,	IL-4,	IL-
10	and	IGF-1	drive	the	conversion	to	an	anti-inflammatory	macrophage	phenotype	to	promote	lung	healing.	
In	 the	context	of	muscle	 regeneration,	 IL-10	also	seems	to	play	a	key	role	 in	 the	phenotypic	switching	of	
muscle	macrophages	 through	 CCAAT/enhancer	 binding	 protein	 beta	 (C/EBPb).	 Even	 though	macrophage	
invasion	 is	 not	 altered	 in	 the	 C/EBPb	 null	 mice	 M2-specific	 genes	 are	 altered	 leading	 to	 impaired	
regeneration.	However,	it	is	important	to	note	that	recent	studies	have	questioned	the	importance	of	M2-
like	macrophages	and	IL-4	in	muscle	regeneration.	Nonetheless,	repair	macrophages	directly	target	satellite	
cells	by	secreting	cytokines	and	growth	factors	to	promote	their	differentiation	into	mature	myotubes.	On	
the	 other	 hand,	 inflammatory	macrophages	 inhibit	myogenic	 precursor	 fusion	 demonstrating	 again	 that	
different	 macrophage	 states	 can	 have	 various	 effects	 on	 satellite	 cell	 fate	 and	 subsequently	 muscle	
regeneration.	Together,	these	studies,	demonstrate	how	the	timely	transition	of	 inflammatory	monocytes	
to	reparative	macrophages	is	critical	for	tissue	regeneration.	
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	 The	 macrophage	 phenotype	 shift	 involves	 many	 other	 molecular	 and	 cellular	 processes.	
Phagocytosis	 of	 neutrophils	 for	 instance,	 controls	 the	 conversion	 and	 in	 case	 phagocytosis	 is	 impaired	
macrophages	 cannot	 acquire	 the	 repair	 phenotype.	 Similar	 to	 acute	 injury	 models	 in	 other	 tissues,	
cytokines	orchestrate	the	conversion	in	muscle	macrophages.	IFN-g	promotes	the	inflammatory	phenotype	
while	inhibiting	the	repair	one.	In	support	of	this	observation	an	increase	in	repair	macrophage	activation	
and	 a	 decrease	 in	muscle	 damage	 have	 been	 observed	 in	 IFN-g	 null	mice.	 At	 the	 cellular	 level	mitogen-
activated	 protein	 kinase	 phosphatase-1	 (MKP-1),	 controls	 the	 phenotypic	 shift	 of	 muscle	 macrophages	
through	regulating	mitogen-activated	protein	kinase	(MAPK)	p38	and	Akt	kinases.	 In	MKP-1	null	mice	the	
transition	occurs	 faster	 resulting	 in	dysregulated	 regeneration.	As	mentioned	 in	 the	previous	 section	 the	
involvement	 of	 AMPK-a1	 in	 the	 phenotypic	 transition	 has	 also	 been	 demonstrated.	 AMPK-a1	 null	 mice	
express	 inflammatory	 cytokines	 at	 higher	 levels	 while	 the	 AMPK-a1	 overexpression	 model	 reveals	 a	
significant	 decrease	 in	 their	 expression.	 These	 studies	 show	 that	 the	 conversion	 of	muscle	macrophages	
from	 inflammatory	 to	 repair	 ones	 is	 finely	 regulated	with	multiple	 targets	 and	pathways	 being	 involved.	
How	all	these	elements	are	regulated	and	coordinated	is	still	unclear.	
• Effector	molecules	and	secreted	growth	factors	in	the	regulation	of	muscle	regeneration.	
Interest	 in	 deciphering	 the	 pathways	 and	 the	 diverse	 macrophage	 subsets	 that	 sustain	 tissue-
damaging	inflammatory	responses	has	increased	lately,	given	that	delineating	the	mechanisms	would	lead	
to	developing	novel	therapeutics	for	various	types	of	inflammatory	diseases.	Following	acute	sterile	muscle	
injury,	macrophages	secrete	cytokine	to	activate	and	enhance	satellite	cell	proliferation	and	differentiation.	
At	the	same	time,	the	tissue	itself	produces	mediators	and	factors	(myokines)	that	act	on	an	autocrine	or	
endocrine	manner	and	influence	the	regeneration	process.	Most	of	the	studies	identifying	these	myokines	
where	 performed	 in	 the	 context	 of	 physical	 activity	 but	 recently	 some	 of	 these	 factors	 have	 been	
discovered	 in	 the	 context	of	muscle	 regeneration	and	 seem	 to	heavily	 impact	 this	process.	 For	example,	
human	myoblasts	 secrete	 IL-6	 in	 response	 to	 IL-1,	 TNF-a	 or	 LPS	 treatment	 in	 vitro	 and	 in	 IL-6	 null	mice	
migration	and	proliferation	of	satellite	cells	is	greatly	diminished.	In	addition,	since	infiltrating	macrophages	
also	secrete	 IL-6	they	 further	stimulate	proliferation	of	satellite	cells.	 In	C2C12	myocyte	cell	cultures,	 IL-6	
has	been	 shown	 to	be	 involved	 in	 the	myocyte	differentiation	program	as	well.	 Inhibiting	 IL-6	decreased	
differentiation	while	overexpression	increased	myotube	formation.	Overall,	these	results	highlight	IL-6	as	a	
myokine	 secreted	 by	 multiple	 sources	 including	 macrophages	 and	 impact	 satellite	 cell	 migration	 to	 the	
injury	site,	proliferation	and	differentiation	into	myotubes.	In	a	recent	study	from	our	lab	and	as	part	of	this	
dissertation	we	 identified	growth	differentiation	 factor	3	 (GDF3),	 a	 secreted	 factor	and	a	member	of	 the	
transforming	growth	factor-β	 family,	 that	already	 includes	known	regulators	of	muscle	regeneration,	as	a	
potent	inducer	of	myotube	formation.	
In	a	similar	fashion,	leukemia	inhibitory	factor	(LIF)	is	another	myokine	secreted	in	the	muscle	during	
exercise	and	regeneration.	Interestingly,	in	vivo	infusion	of	LIF	enhances	regeneration	by	directly	acting	on	
proliferation	 and	 differentiation	 of	 satellite	 cells.	 In	 vitro,	 LIF	 activates	 C2C12	 maturation	 through	 the	
JAK2/STAT2	pathway,	while	targeting	of	the	LIF	receptor	with	siRNA	markedly	decreases	human	myoblast	
proliferation.	 In	human	skeletal	muscle	 interleukin	7	(IL-7)	seems	to	have	similar	 function	on	satellite	cell	
differentiation	and	similarly	targeting	the	IL-7	receptor	decreases	their	maturation	to	myotubes	in	vitro.	In	
addition,	recombinant	IL-7	treatment	activates	satellite	cell	migration	but	inhibits	their	maturation.	Thus,	in	
the	context	of	muscle	 injury	and	regeneration,	 IL-7	 is	 involved	guiding	the	satellite	cells	 to	 the	 injury	site	
and	 keeps	 them	 from	 differentiating	 until	 the	 proper	 signals	 overcome	 this	 inhibition.	 Interleukin	 4	 is	
another	 cytokine	 proposed	 to	 affect	 satellite	 cell	 differentiation	 and	myotube	 formation	 through	 fusion.	
CXC	ligand	1	(CXCL-1)	and	interleukin	8	(IL-8)	are	another	group	of	myokines	that	 impact	regeneration	by	
attracting	neutrophils	to	the	injury	site,	although	their	exact	mode	of	action	in	skeletal	muscle	regeneration	
is	 still	 not	 clear.	 During	 aging,	 production	 of	 these	 cytokines/myokines	 is	 either	 diminished	 or	 altered,	
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leading	to	declining	muscle	function.	Thus,	it	will	be	interesting	for	future	studies	to	address	the	potential	
effect	these	molecules	could	have	in	restoring	the	age-related	muscle	repair	inefficiency.	
• Muscle	resident-immune	cell	cross-talk	during	regeneration	
Skeletal	 muscle	 regeneration	 is	 a	 collection	 of	 highly	 synchronized	 processes	 involving	 several	
cellular,	 molecular	 and	 signaling	 responses.	 Coordinating	 inflammation	 and	 regeneration	 is	 particularly	
important	 for	 efficient	 repair	 (ad	 integrum)	 following	 acute	 injury.	 A	 chief	 reason	 for	 the	 lack	 of	 better	
understanding	of	muscle	repair	 is	that	skeletal	muscle	tissue	comprises	many	different	cell	 types,	such	as	
satellite	 cells,	 fibroblasts,	 fibro/adipogenic	progenitors	 (FAPs),	 endothelial	 and	periendothelial	 cells,	mast	
cells,	 macrophages	 (resident	 and	 patrolling	 circulatory	 monocytes)	 and	 T	 cells,	 which	 can	 all	 affect	 the	
myofiber	 environment.	 Any	 disturbance	 of	 these	 cells’	 interactions	 could	 disrupt	 tissue	 homeostasis	 and	
consequently	 repair.	 Satellite	 cells	 are	 known	 to	 be	 key	 regulators	 of	 the	 skeletal	muscle	 compartment.	
These	cells	are	undifferentiated	myogenic	cells	that	are	found	between	the	sarcolemma	and	basal	lamina,	
and	can	fuse	to	establish	new	myofibres.	These	quiescent	cells	mature	into	post	mitotic	myofibres	through	
specific	 extracellular	 signals.	 Initially	 these	 paracrine	 or	 autocrine	 signals	 result	 in	 myoblast	 expansion	
followed	by	 pro-differentiation	 signals	 that	 are	 required	 to	 induce	 their	maturation.	 The	 exact	 nature	of	
such	signals	is	still	not	clearly	defined.	Many	candidate	molecules	have	been	proposed	to	mediate	myoblast	
differentiation	 such	 as	 IL-6,	 insulin	 growth	 factors,	 and	 more	 recently	 growth	 differentiation	 factors,	
supporting	the	notion	that	a	range	of	factors	are	involved	in	this	differentiation	process.	Furthermore,	only	
recently	we	started	to	understand	which	cell	types	(FAPs	and	macrophages)	are	responsible	for	producing	
these	factors.	In	the	context	of	muscle	regeneration	following	acute	sterile	injury,	the	satellite	cells	interact	
primarily	with	inflammatory	and	stromal	cells,	i.e.	fibroblasts,	pericytes	and	FAPs.	Importantly,	it	has	been	
suggested	 that	 the	 cross-talk	 between	 these	 tissue	 compartments	 is	 crucial	 both	 in	 regulating	myoblast	
expansion	and	differentiation	and	 regarding	 the	outcome	of	 skeletal	muscle	 regeneration.	However,	 it	 is	
not	 known	 how	 cross-talk	 between	 satellite	 cells	 and	 other	 tissue	 compartments	 contributes	 to	
synchronized	 repair.	 At	 the	 same	 time,	 the	 field	 lacks	 adequate	 methodology	 to	 study	 and	 thoroughly	
delineate	the	exact	nature	of	such	interactions.	
Nonetheless,	 it	 is	 known	 that	 repair	 macrophages	 activate	 angiogenesis	 and	 induce	 satellite	 cell	
differentiation.	 A	model	 of	 repair	macrophage	 depletion	 (CCR2	 −/−	mice),	 shows	 the	 importance	 of	 this	
subtype	 in	 regeneration,	 while	 in	 vitro	 studies	 demonstrate	 that	 these	 cells	 enhance	 the	 expression	 of	
myogenin	(muscle	differentiation	marker),	and	myocyte	fusion.	In	human	muscle	biopsies	after	exercise,	it	
is	being	shown	that	the	repair	macrophages	co-localize	with	differentiating	satellite	cells.	Insulin-like	growth	
factor-1	(IGF-1)	 is	an	important	hormone	secreted	by	the	repair	macrophages	acting	on	satellite	cells	and	
seems	to	restore	proper	regeneration	dynamics	when	administered	exogenously.	With	aging	satellite	cell	
proliferation	and	differentiation	capacity	declines,	as	well	as	macrophage	cytokine	production.	Knowing	the	
key	 role	 of	macrophages	 in	 regulating	 satellite	 cell	 function,	 one	 can	 assume	 that	 changes	 due	 to	 aging	
affects	 muscle	 regeneration.	 However,	 it’s	 still	 unclear	 how	 aging	 affects	 satellite	 cell	 function	 and	
macrophage	 phenotypic	 transition,	 and	 their	 subsequent	 immune/muscle	 cell	 crosst-talk.	 Such	work	will	
help	us	to	develop	approaches	to	preserve	the	muscle	regenerative	capacity	in	aged	individuals.		
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Aims	
	
Our	 work	 focused	 on	 identifying	 multi-level	 interactions	 between	 inflammatory	 and	 repair	
macrophages	 and	 skeletal	 muscle	 cells	 during	 regeneration	 and	 repair.	 Our	 long-term	 goal	 has	 been	 to	
identify	 and	 characterize	 sensory,	 regulatory	 and	 effector	 functions	 ascribable	 to	 macrophages	 during	
muscle	regeneration	and	tissue	repair.	We	have	used	unbiased	genomic	approaches	 (RNA-seq	and	ATAC-
seq)	combined	with	advanced	cell	 separation	 from	 injured	and	regenerating	 tissues	 to	 identify	molecules	
likely	 to	 be	 required	 as	 sensors	 of	 the	 environment,	 regulators	 of	 transcription	 during	 the	macrophage	
phenotypic	 switch,	 and	 effector	 molecules	 contributing	 to	 myoblast	 proliferation,	 differentiation	 and	
myofiber	formation.		
	
Specific	aims:	
1. Assessing	 the	 role	 of	 newly	 identified	 sensors	 and	 regulators	 in	 a	 model	 of	 skeletal	 muscle	
regeneration	(CTX):	
a) Lipid	activated	transcription	factor	PPARg:	
• In	vivo	molecular	analysis	of	macrophage	PPARg	function	in	inflammation	and	tissue	injury	
(fiber	size	distribution,	necrotic	clearance).	
• Identification	of	PPARg	target	genes	using	gene	expression	profiling	and	characterization	of	
the	contribution	of	these	genes	to	muscle	regeneration.	
b) Heme	sensor	and	transcriptional	repressor	BACH1:	
• In	 vivo	 molecular	 analysis	 of	 macrophage	 BACH1	 function	 in	 macrophage	 dynamic	
phenotype	switch,	cell	invasion,	gene	expression,	inflammation	and	tissue	injury	(fiber	size	
distribution,	necrotic	clearance).	
• Identification	of	BACH1	target	genes	using	gene	expression	profiling	and	characterization	
of	the	contribution	of	these	genes	to	muscle	regeneration.	
	
2. Assessing	 the	 role	 of	 newly	 identified	 effector	molecules	 in	 an	 acute	 sterile	muscle	 injury	model	
(CTX):	
a) Growth	differentiation	factor	GDF3:	
• In	 vivo	 molecular	 analysis	 of	 macrophage	 secreted	 GDF3	 in	 muscle	 injury	 (fiber	 size	
distribution).	
• GDF3	role	 in	primary	myoblasts	and	aged	muscles	 (in	vivo	administration	of	recombinant	
protein).	
b) Growth	differentiation	factor	GDF15:		
• In	 vivo	 molecular	 analysis	 of	 macrophage	 GDF15	 function	 in	 macrophage	 dynamic	
phenotype	switch,	cell	invasion	and	tissue	injury	(fiber	size	distribution).	
c) Heme	catabolizing	enzyme	HMOX1:	
• In	 vivo	 molecular	 analysis	 of	 macrophage	 HMOX1	 in	 macrophage	 dynamic	 phenotype	
switch,	cell	invasion,	and	tissue	injury	(fiber	size	distribution,	necrotic	clearance).	
	
3. Explore	 the	 potential	 existence	 of	 a	 reciprocal	 cross-talk	 between	 the	 skeletal	muscle	 tissue	 and	
myeloid	cells	recruited	following	acute	injury:	
a) Use	two	in	vivo	models	as	a	mean	to	alter	cellular	composition	prior	to	muscle	injury:	
• Irradiation.	
• Genetic	ablation	of	a	specific	muscle	cell	population	(PAX7+	cells).	
b) Use	bone	marrow	transplantation	to	replenish	myeloid	cells.	
c) Use	PET-MRI	in	vivo	imaging	to	monitor	the	myeloid	cell	phenotypic	switch	in	situ.	
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Materials	and	Methods	
	
Ethical	approval:		
All	 animal	 experiments	 were	 carried	 out	 in	 accordance	 with	 guidelines	 prescribed	 by	 the	 Institutional	
Animal	Care	and	Use	Committee	at	Sanford	Burnham	Prebys	Medical	Discovery	Institute	and	University	of	
Debrecen,	 School	 of	 Medicine	 following	 Hungarian	 (license	 no.:	 21/2011/DEMÁB)	 and	 European	
regulations.	
	
Mice:		
Wild	 type	BoyJ	 (B6.SJL-Ptprca	Pepcb	 /BoyJ,	 stock	number	002014)	and	C57BL/6J	male	 control	mice	were	
obtained	 from	 the	 Jackson	 Laboratories	 and	 bred	 under	 specific-pathogen	 free	 (SPF)	 conditions.	
Ppargfl/flLysMCre+	 (refered	 to	 as	 PPARg	MacKO),	 Gdf15	 KO	 (provided	 by	 Dr.	 Se-Jin	 Lee	 at	 John	 Hopkins	
University),	 Bach1	 KO	 (obtained	 by	 Dr.	 Kazuhiko	 Igarashi	 at	 Tohoku	 University),	 Hmox1fl/fl	 LysMCre	
(obtained	by	Dr.	George	Kollias	at	BSRC-Athens),	Gdf3	KO	(provided	by	Dr.	Chester	Brown	at	Baylor	College	
of	Medicine),	and	littermate	C57BL/6	albino	controls	were	used	in	the	experiments.	Mice	of	23-28	month-
old	were	obtained	by	GlaxoSmithKline.	Experiments	were	conducted	on	adult	 (2-6	month-old)	male	mice	
unless	 otherwise	 noted.	 For	 in	 vivo	 heme	 treatments	 mice	 were	 treated	 with	 either	 30	 mg/kg	 hemin	
(Sigma)	 or	 saline	 daily.	 All	 irradiation	 experiments	 were	 performed	 under	 anesthesia	 in	 cohorts	 of	 12	
animals	 per	 experiment.	 Briefly,	 mice	 were	 anaesthetized	 with	 a	 single	 intraperitoneal	 dose	 of	
ketamine/xylazine	 (ketamine	 80-100	 mg/kg,	 xylazine	 10-12.5	 mg/kg).	 Irradiated	 and	 bone	 marrow	
transplanted	mice	were	maintained	 in	an	SPF	status	 (autoclaved	top	 filter	cages)	 for	 the	entire	course	of	
experimentation	 and	 antibiotics	 (amoxicillin	 antibiotic,	 clavulanic	 acid	 [500mg/	 125	mg/	 liter	 of	 drinking	
water])	were	 administered	 in	 the	 drinking	water	 for	 4	weeks	 after	 transplantation	 to	minimize	 bacterial	
contamination	within	 the	water	 source	 and	 potentially	 decrease	 the	 burden	 of	 gastrointestinal	 bacteria.	
Irradiated	mice	were	also	fed	autoclaved	rodent	chow	ad	libitum.	Animals	that	undergo	irradiation	for	BMT	
typically	 lose	 a	 considerable	 amount	 of	 weight,	 only	 to	 gain	 it	 back	 relatively	 quickly	 after	 successful	
transplantation.	At	our	 institutions,	weight	 loss	of	20%,	or	greater	was	used	as	a	rationale	for	euthanasia	
before	 the	 intended	 experimental	 endpoint	 according	 to	 the	 IACUC	 guidelines.	 The	 Pax7CreER/+,	
Rosa26DTA/+	 strain,	 designated	 Pax7-DTA,	 was	 generated	 by	 crossing	 Pax7CreER/CreER	 and	
Rosa26DTA/DTA	 strains.	 Pax7-DTA	 pups	 were	 genotyped	 by	 PCR	 are	 as	 previously	 described	 (Nishijo,	
Hosoyama	et	al.	2009),	(Wu	2006).	The	tamoxifen-treated	mice	were	kindly	provided	by	Dr.	John	McCarthy	
and	 Dr.	 Charlotte	 Peterson.	 When	 necessary	 and	 for	 tissue	 collection	 mice	 were	 euthanized	 by	 either	
isoflurane	overdose	(adjusted	flow	rate	or	concentration	to	5%	or	greater)	or	CO2	exposure	(adjusted	flow	
rate	3	L/min)	in	accordance	to	the	University	of	Debrecen	and	Sanford	Burnham	Prebys	Medical	Discovery	
Institute’s	IACUC	guidelines.		
	
Bone	Marrow	Transplantation	(BMT):	
Recipient	congenic	BoyJ	mice	(7	weeks	old)	are	irradiated	with	9.5	or	11	Gy	using	a	Theratron	780C	cobalt	
unit	for	the	ablation	of	the	recipient	bone	marrow.	The	animals	to	be	irradiated	were	immobilized	using	a	
circular	cage	(mouse	pie	cage)	that	can	hold	up	to	11	mice	(alert	mice).	Following	the	irradiation,	isolated	
bone	marrow	 cells	 (in	 sterile	 RPMI-1640	medium)	 flushed	 out	 from	 the	 femur,	 tibia	 and	 humerus	were	
transplanted	into	the	recipient	mice	by	retro-orbital	injection	(20x106	BM	cells	per	mice).	This	experimental	
BMT	CD45	congenic	model	allows	us	to	detect	donor,	competitor	and	host	contribution	in	hematopoiesis	
and	 repopulation	 efficiency	 of	 donor	 cells	 (congenic	 mice	 with	 CD45.1	 versus	 CD45.2).	 The	 CD45.1	 and	
CD45.2	contribution	is	detected	by	flow	cytometry	at	8-12	weeks	following	the	BMT.	In	short,	a	cut	at	the	
tail	tip	of	the	mice	provided	a	drop	of	blood	that	was	placed	into	0.5	ml	PBS	+	1%	FBS	+	10	U/ml	Heparin	
buffer	 (samples	 kept	 on	 ice).	 The	 cells	 were	 directly	 stained	 by	 2	 μl	 (1/50	 dilution)	 mouse	 anti-mouse	
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CD45.2-FITC	 (clone	 104)	 and	 2	 μl	 (1/50	 dilution)	 rat	 anti-mouse	 GR1-PE	 (clone	 RB6-8C5)	 antibodies	 (BD	
Pharmingen)	and	 incubated	on	 ice	 for	30	min.	After	2	washes	with	 ice-cold	PBS/FBS/Heparin	buffer,	cells	
were	resuspended	in	0.5-1	ml	FACS	Lysing	solution	(BD	Cat	#349202).	Cells	where	then	incubated	for	5	min	
at	RT	and	centrifuged	 (400g,	5	min,	4°C).	 	The	double	stained	samples	were	 run	on	BD	FACS	Calibur	and	
determined	the	ratio	of	donor	cells.	The	repopulation	is	always	gated	on	the	granulocyte	fraction	based	on	
FSC,	SSC	and	Gr1	staining.		
	
Bone	Marrow	Transplantation	(BMT)	including	local	radioprotection:		
A	modification	of	 the	above	protocol	was	used	by	 introducing	hindlimb	 lead	shielding.	The	animals	 to	be	
irradiated	were	anesthetized	via	intraperitoneal	injection	of	ketamine	(80	mg/kg)	and	xylazine	(10	mg/kg),	
and	placed	into	a	plastic	box,	with	double	wall.	Water	was	used	between	the	walls,	as	scattering	medium,	in	
order	to	get	homogeneous	dose	distribution.	Two	5	cm	high	led	blocks	were	used	for	protection	one	of	the	
legs	of	the	mouse.	The	blocks	were	on	the	PMMA	shadow	tray	of	the	cobalt	unit,	more	than	20	cm	distance	
to	 the	 surface	of	 the	plastic	 box,	 so	 the	 air	 absorbs	 the	Compton	electrons	 from	 the	blocks.	 In	 order	 to	
account	for	the	buildup	region	of	cobalt	energy,	5	mm	thickness	top	box	plate	was	used.	The	source	surface	
distance	(SSD)	and	source	axis	distance	(SAD)	was	80	cm	and	the	beam	size	covered	21	x	21	cm.	The	activity	
of	the	Cobalt-60	isotope	was	about	50	TBq	(1350	Ci).	Animals	were	generally	irradiated	for	short	periods	of	
time	 (20-30	min	as	a	 function	of	 the	given	date)	depending	on	the	radioisotope	decay	charts,	amount	of	
irradiation	 needed,	 and	 source	 of	 ionizing	 energy.	 Following	 the	 irradiation,	 isolated	 bone	marrow	 cells	
from	donor	C57BL/6J	mice	were	transplanted	into	the	recipient	mice	by	retro-orbital	injection.	
	
Lower	body	irradiation:		
For	 this	method	 5	 cm	 thick	 lead	 blocks	were	 used	 during	 irradiation,	 to	 protect	 one	 of	 the	 back	 legs	 of	
lightly	sedated	mice.	We	focused	the	radiation	field	(14.4	x	4.8	cm)	only	 in	the	 lower	part	of	their	bodies	
just	below	the	hip	thus	minimizing	radiation	exposure	to	the	rest	of	the	body.	The	source	surface	distance	
(SSD)	and	source	axis	distance	(SAD)	was	kept	the	same	and	mice	were	irradiated	with	a	dose	of	11	Gy.	The	
animals	left	to	recover	for	8	weeks	after	the	radiation	exposure.	
	
Acute	sterile	muscle	injury:		
Mice	 were	 anaesthetized	 with	 isoflurane	 (adjusted	 flow	 rate	 or	 concentration	 to	 1.5	 %)	 and	 50	 µl	 of	
cardiotoxin	(12X10-6	M	in	PBS)	(from	Latoxan)	was	injected	in	the	tibialis	anterior	(TA)	muscle.	Muscles	were	
isolated	for	flow	cytometry	analysis	at	day	1	to	day	8	post-injury	or	for	muscle	histology	at	day	8	to	day	20	
post-injury.		
	
Histological	analysis	of	muscle	regeneration:		
Muscles	were	 removed	and	 snap	 frozen	 in	nitrogen-chilled	 isopentane	 (–160°C).	 8	µm	 thick	 cryosections	
were	 cut	 and	 stained	with	 hematoxylin-eosin	 (H&E).	 For	 each	 histological	 analysis,	 at	 least	 5	 slides	 (per	
condition)	were	selected	where	the	total	regenerative	region	within	the	CTX	injured	TA	muscle	was	at	least	
70%.		For	each	TA,	myofibers	in	the	entire	injured	area	were	counted	and	measured.	H&E	muscle	sections	
were	scanned	with	Mirax	digital	slide	scanner	and	the	Cross	Sectional	Area	(CSA)	was	measured	with	HALO	
software	 (Indica	 Labs).	 CSAs	 for	 these	 samples	 are	 reported	 in	 µm2.	 Quantitative	 analysis	 of	
necrotic/phagocytic	vs.	centrally	nucleated	myofibers	was	performed	using	the	Panoramic	Viewer	software	
and	was	expressed	as	a	percentage	of	the	total	number	of	myofibers.	Necrotic/phagocyted	myofibers	were	
defined	as	pink	pale	patchy	fibers	that	are	invaded	by	basophil	single	cells	(macrophages).	
	
Immunohistochemistry	(Frozen	sections):		
Tissue	sections	were	fixed	and	permeabilized	in	ice	cold	acetone	for	5	min	and	blocked	for	30	minutes	at	20	
°C	(room	temperature)	in	PBS	containing	2	%	bovine	serum	albumin	(BSA).	Tissues	were	stained	for	1	h	at	
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room	 temperature	 using	 a	 primary	 antibody	 diluted	 in	 2	 %	 BSA.	 The	 primary	 antibodies	 used	 for	
immunofluorescence	 were	 rabbit	 anti-laminin	 (L9393	 SIGMA)	 at	 a	 dilution	 of	 1/200,	 chicken	 anti-PAX7	
(DSHB)	at	a	dilution	of	1/20,	 rabbit	anti-Desmin	 (Abcam	32362)	at	a	dilution	of	1/200	and	 rat	anti-F4/80	
(Abcam	 6640)	 at	 a	 dilution	 of	 1/200.	 In	 all	 cases,	 the	 primary	 antibody	 was	 detected	 using	 secondary	
antibodies	(dilution	1/200)	conjugated	to	FITC	(JIR	703-095-155)	or	Cy3	JIR	(711-165-152).	The	nuclei	were	
counter	 stained	with	 0.1-1	 μg/ml	 Hoechst.	 Fluorescent	microscopy	was	 performed	 using	 Carl	 Zeiss	 Axio	
Imager	Z2	microscope	equipped	with	lasers	at	488,	568	and	633	nm.	Figures	were	analyzed	and	assembled	
using	Fiji	(image	processing	package	based	on	ImageJ)	and	Illustrator	CS5	(Adobe).	
		
In	vivo	Isolation	of	macrophages	from	muscle:		
Fascia	 of	 the	 TA	was	 removed.	Muscles	were	 dissociated	 in	 RPMI	 containing	 0.2%	 collagenase	 B	 (Roche	
Diagnostics	GmbH)	at	37°C	for	1	hour	and	filtered	through	a	100	µm	and	a	40	µm	filter.	CD45+	cells	were	
isolated	using	magnetic	sorting	(Miltenyi	Biotec).	For	FACS,	macrophages	were	treated	with	5%	Fcγ	receptor	
blocking	 antibodies	 and	with	 10%	 normal	 rat	 serum:	 normal	mouse	 serum	 1:1	mix,	 then	 stained	with	 a	
combination	 of	 PE-conjugated	 anti-Ly6C	 antibody	 at	 a	 dilution	 of	 1/200	 (HK1.4,	 eBioscience),	 APC-
conjugated	F4/80	antibody	at	a	dilution	of	1/50	(BM8,	eBioscience)	and	FITC-conjugated	Ly6G	antibody	at	a	
dilution	1/100	(1A8,	Biolegend).	Ly6Chigh	F4/80low	macrophages,	Ly6Clow	F4/80high	macrophages	and	Ly6Ghigh	
Ly6Cmed	F4/80-	neutrophils	were	quantified.	In	each	experiment,	control	samples	were	processed	in	parallel	
to	minimize	experimental	variation.	Cells	were	analyzed	on	a	BD	FACSAria	III	sorter	and	data	analysis	was	
performed	using	BD	FACSDIVA	(BD	Biosciences)	and	FlowJo	V10	(FlowJo,	LLC)	software.		
	
RNA	isolation:		
Total	 RNA	 was	 isolated	 with	 TRIZOL	 reagent	 according	 to	 the	 manufacturer’s	 recommendation.	 20ug	
glycogen	(Ambion)	was	added	as	carrier	for	RNA	precipitation.		
	
RT-qPCR:		
Transcript	 quantification	 was	 performed	 by	 quantitative	 real-time	 RT	 (reverse	 transcriptase)	 PCR	
(polymerase	 chain	 reaction)	 using	 SYBR	 Green	 assays.	 RT-qPCR	 results	 were	 analyzed	with	 the	 standard	
delta	Ct	method	and	results	were	normalized	to	the	expression	of	Rps26	or	Ppia.	
	
Small	animal	PET-MRI	imaging	using	18F-FDG:		
PET-MRI	experiments	were	conducted	during	the	 light	cycle	to	minimize	muscle	activity.	C57BL/6	or	BoyJ	
mice	were	injected	with	8.0	±	0.2	MBq	of	18F-FDG	via	the	lateral	tail	vein	in	200	μl	volume.	50	min	after	18F-
FDG	injection	animals	were	anaesthetized	by	3%	isoflurane	with	a	dedicated	small	animal	anesthesia	device	
and	whole	body	PET	scans	(10	min	static	PET	scans)	were	acquired	using	the	preclinical	nanoScan	PET/MRI	
system	 (Mediso	 Ltd.,	 Hungary).	 To	 prevent	 movement,	 the	 animals	 were	 fixed	 to	 a	 mouse	 chamber	
(MultiCell	Imaging	Chamber,	Mediso	Ltd.,	Hungary)	and	positioned	in	the	center	of	field	of	view	(FOV).	For	
the	determination	of	 the	 anatomical	 localization	of	 the	organs	 and	 tissues,	 T1-weighted	MRI	 scans	were	
performed	(3D	GRE	EXT	multi-FOV;	TR/TE	15/2	ms;	FOV	70	mm;	NEX	2).	PET	volumes	were	reconstructed	
using	 a	 three-dimensional	 Ordered	 Subsets	 Expectation	Maximization	 (3D-OSEM)	 algorithm	 (Tera-Tomo,	
Mediso	 Ltd.,	Hungary).	 PET	 and	MRI	 video	 and	 images	were	 automatically	 co-registered	by	 the	 PET/MRI	
instrument’s	 acquisition	 software	 (Nucline).	 Reconstructed,	 reoriented	 and	 co-registered	 images	 were	
further	analyzed	with	InterView™	FUSION	(Mediso	Ltd.,	Hungary)	dedicated	image	analysis	software.	
	
PET	data	analysis:		
Radiotracer	uptake	was	expressed	in	standardized	uptake	values	(SUVs).	Ellipsoidal	3-dimensional	Volumes	
of	 Interest	 (VOI)	 were	 manually	 drawn	 around	 the	 edge	 of	 the	 TA	 and	 GAST	 muscle	 activity	 using	
InterView™	 FUSION	 multi-modal	 visualization	 and	 evaluation	 software	 (Mediso	 Ltd.,	 Hungary).	 The	
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standardized	uptake	value	 (SUV)	was	calculated	as	 follows:	SUV	=	 [VOI	activity	 (Bq/mL)]/[injected	activity	
(Bq)/animal	weight	(g)],	assuming	a	density	of	1	g/mL	
	
Ex	vivo	radiotracer	uptake	studies:		
Cells	were	 isolated	 from	 injured	muscles	as	described	above.	 Live	 cells	 for	both	myeloid	CD45+	and	non-
myeloid	CD45-	 fractions	were	selected	using	FACS-sorting	based	on	FSC/SSC	gating	and	then	washed	and	
resuspended	in	PBS	containing	1	mM	glucose.	The	samples	were	pre-incubated	at	36	°C	for	10	min	at	a	cell	
concentration	of	1	×	106	/ml	 in	PBS	and	0.37	MBq/ml	18F-FDG	was	then	added	to	each	sample.	After	 the	
addition	of	the	radioligand,	cells	were	further	incubated	at	36	°C	for	50	min	and	the	uptake	was	terminated	
by	the	addition	of	ice-cold	PBS.	The	cells	were	then	washed	three	times	with	cold	PBS	and	resuspended	in	1	
ml	 of	 cold	 PBS,	 and	 the	 radioactivity	 was	 measured.	 The	 tubes	 were	 measured	 in	 a	 Canberra	 Packard	
gamma-counter	for	1	min	within	the	18F-sensitive	energy	window.	Decay-corrected	radiotracer	uptake	was	
expressed	as	counts	min−1	 (106	cells)−1	 (cpm).	The	displayed	data	are	 the	means	±	SD	of	 the	 results	of	at	
least	three	independent	experiments,	each	performed	in	triplicate.	
	
Expression	data	processing	and	analysis:		
GSE71155	data	sets	were	loaded	into	the	Genespring	GX	software,	and	multiarray	average	summarization	
was	 carried	 out.	 Next,	 the	 lowest	 5%	 of	 the	 entities	 with	 detectable	 signals	 were	 ﬁltered	 out	 as	 not	
expressed.	 Duplicate	 entities,	 not/poorly	 annotated	 transcripts	 and	 transcripts	 reporting	 inconsistent	
expression	values	were	also	discarded.	Further	analysis	was	carried	out	on	the	ﬁltered	data	set	based	on	
the	 RAW	 expression	 values.	 Heatmap	 was	 generated	 based	 on	 log10-transformed	 raw	 values	 with	 R	
software	 package	 pheatmap.	 Hierarchical	 clustering	 analysis	 was	 then	 applied	 by	 Euclidean	 distance	
measure	and	Ward’s	clustering	algorithm,	to	ﬁnd	correlated	genes.	
	
Myogenic	precursor	cell	(MPC)	culture:	
Murine	MPCs	were	obtained	from	TA	muscles	and	cultured	using	standard	conditions	in	DMEM/	F12	(Gibco	
Life	Technologies)	 containing	20%	FBS	and	2%	G/Ultroser	 (Pall	 Inc).	 For	proliferation	 studies,	MPCs	were	
incubated	for	1	day	with	conditioned	medium	+	2.5%	FBS	or	with	2.5%	FBS	medium	containing	100-600	ng	
of	GDF3	or	GDF15	mouse	 recombinant	protein.	Cells	were	 then	 incubated	with	anti-Ki67	antibodies	 at	 a	
dilution	 of	 1/200	 (15580	 Abcam),	 which	 were	 subsequently	 visualized	 using	 Cy3-conjugated	 secondary	
antibodies	 at	 a	 dilution	 of	 1/200	 (Jackson	 Immunoresearch	 Inc).	 For	 differentiation	 studies,	MPCs	 were	
incubated	for	3	days	with	conditioned	medium	containing	2%	horse	serum	or	with	2%	horse	serum	medium	
containing	 300	 ng/ml	 recombinant	 GDF3.	 Cells	 were	 then	 incubated	 with	 anti-Desmin	 antibodies	 at	 a	
dilution	 of	 1/200	 (32362	 Abcam),	 and	 in	 combination	 with	 a	 Cy3-conjugated	 secondary	 antibody	 at	 a	
dilution	of	1/200	(Jackson	Immunoresearch	Inc).	
	
Image	capture	and	analysis	for	myoblast	cultures:		
Fusion	 index	 (for	myogenic	cells)	was	calculated	as	 the	number	of	nuclei	within	myotubes	divided	by	the	
total	 number	of	 nuclei.	 The	nuclei	 number	was	estimated	based	on	DAPI	 staining	 and	using	 the	 Image	 J	
software.	Desmin	staining	was	used	for	detecting	the	myotubes.	
	
Microarray	analysis	of	muscle	macrophages:		
Global	expression	pattern	was	analyzed	on	Affymetrix	GeneChip	Mouse	Gene	1.0	ST	arrays.	The	microarray	
data	are	publicly	available	(Data	access:	GSE71155).	
	
Western	Blotting:		
GDF3	and	GDF15	protein	expression	was	measured	using	Western	Blot	analysis.	Samples	from	CTX	injected	
TA	 muscles	 were	 lysed	 in	 RIPA	 buffer.	 GDF3	 was	 targeted	 using	 rabbit	 monoclonal	 Anti-GDF3	 primary	
	 17	
antibody	(ab109617,	Abcam,	Cambridge,	MA)	at	1:1000	dilution	in	5%	BSA/TBS-T	overnight	at	4°C.	GDF15	
was	 targeted	using	 rabbit	polyclonal	 (ab105738,	Abcam)	at	1:1000	dilution	 in	5%	BSA/TBS-T	overnight	at	
4°C.	 Anti-GAPDH	 mouse	 monoclonal	 primary	 antibody	 (AM4300,	 Ambion,	 Carlsbad,	 CA)	 was	 used	 as	 a	
protein	loading	control	at	1:10000	–	1:20000	dilution	in	5%	BSA/TBST	overnight	at	4°C.		
	
RNA	sequencing	(RNA-Seq)	library	preparation:		
cDNA	library	for	RNA-Seq	was	generated	from	100-400	ng	total	RNA	using	TruSeq	RNA	Sample	Preparation	
Kit	 (Illumina,	 San	 Diego,	 CA,	 USA)	 according	 to	 the	 manufacturer’s	 protocol.	 Briefly	 poly-A	 tailed	 RNA	
molecules	were	pulled	down	with	poly-T	oligo	attached	magnetic	beads.	Following	purification,	mRNA	was	
fragmented	 with	 divalent	 cations	 at	 85oC,	 and	 then	 cDNA	 was	 generated	 by	 random	 primers	 and	
SuperScript	II	enzyme	(Life	Technologies).	Second	strand	synthesis	was	performed	followed	by	end	repair,	
single	 `A`	base	addition	and	 ligation	of	barcode	 indexed	adaptors	to	the	DNA	fragments.	Adapter	specific	
PCRs	 were	 performed	 to	 generate	 sequencing	 libraries.	 Libraries	 were	 size	 selected	 with	 E-Gel	 EX	 2%	
agarose	 gels	 (Life	 Technologies)	 and	 purified	 by	 QIAquick	 Gel	 Extraction	 Kit	 (Qiagen).	 Libraries	 were	
sequenced	on	HiSeq	2500	instrument.	Three	biological	replicates	were	sequenced	for	each	population.	
	
RNA-seq	analysis:	
RNA-seq	samples	were	analyzed	according	to	the	pipeline	described	in	Barta	et	al.	2011.	Briefly,	the	50	bp	
raw	single	reads	were	aligned	using	TopHat	(Kim	et	al.	2013)	to	the	mm10	genome	assembly	(GRCm38)	and	
only	 the	 uniquely	 mapped	 reads	 were	 kept	 using	 ‘--max-	 multihits	 1’	 option,	 otherwise	 the	 default	
parameters	were	used.	SAMtools	(Li	et	al.	2009)	was	used	for	indexing	the	alignment	files.	Coverage	density	
tracks	(wig	files)	for	RNA-seq	data	were	generated	by	 igvtools	with	‘count’	command	and	then	converted	
into	tdf	files	using	‘toTDF’	option.	Genes	with	CPM	(counts	per	million)	>=	10	(at	least	in	one	sample)	were	
considered	to	be	expressed.	Statistically	significant	difference	was	considered	as	p	value	<	0.05	from	GLM	
test	using	R	package	edgeR	(Robinson,	McCarthy	et	al.	2010).	Data	analysis	was	also	performed	using	Strand	
NGS	software,	Version	2.8,	Build	230243	(Strand	Life	Sciences).	Aligned	reads	were	loaded	into	Strand	NGS	
before	 performing	 DESeq	 normalization	 for	 hierarchical	 clustering	 analysis	 (Euclidean	 similarity	measure	
and	 Ward’s	 linkage	 rule	 used),	 and	 data	 visualization	 using	 Principal	 Component	 Analysis	 (PCA).	 When	
comparing	data	across	three	or	more	groups,	the	obvious	option	is	to	use	the	One-way	ANOVA	statistical	
test.	The	One-Way	ANOVA	takes	a	comprehensive	approach	in	analyzing	data	and	attempts	to	extend	the	
logic	 of	 t-tests	 to	 handle	 three	 or	 more	 groups	 concurrently.	 It	 uses	 the	 mean	 of	 the	 sum	 of	 squared	
deviates	(SSD)	as	an	aggregate	measure	of	variability	between	and	within	groups.	It	assumes	independent	
and	 random	 samples	 drawn	 from	 a	 normally	 distributed	 source.	 Additionally,	 it	 also	 assumes	 that	 the	
groups	have	approximately	equal	variances,	which	can	be	practically	enforced	by	requiring	the	ratio	of	the	
largest	 to	 the	 smallest	 group	 variance	 to	 fall	 below	 a	 factor	 of	 1.5.	 These	 assumptions	 are	 especially	
important	 in	 case	 of	 unequal	 group-sizes.	 When	 group-sizes	 are	 equal	 (samples	 are	 independent	 and	
random)	 like	 in	 the	 CTX	model,	 the	 test	 is	 amazingly	 robust,	 and	 holds	 well	 even	 when	 the	 underlying	
source	distribution	is	not	normal.	The	significant	ANOVA	result	suggests	rejecting	the	null	hypothesis	H0	=	
‘‘means	are	the	same’’.	 It	does	not	tell	which	means	are	significantly	different.	For	a	given	gene,	if	any	of	
the	group	pair	 is	significantly	different,	 then	 in	ANOVA	test	 the	null	hypothesis	will	be	rejected.	Post	hoc	
tests	 are	 multiple	 comparison	 procedures	 commonly	 used	 on	 only	 those	 genes	 that	 are	 significant	 in	
ANOVA	 F-test.	 The	 most	 common	 post	 hoc	 test	 is	 Tukey’s	 Honestly	 Significant	 Difference	 or	 HSD	 test.	
Tukey’s	test	calculates	a	new	critical	value	that	can	be	used	to	evaluate	whether	differences	between	any	
two	pairs	of	means	are	significant.	One	simply	calculates	one	critical	value	and	then	the	difference	between	
all	possible	pairs	of	means.	Each	difference	is	then	compared	to	the	Tukey	critical	value.	If	the	difference	is	
larger	than	the	Tukey	value,	the	comparison	is	significant.	Next	multiple	testing	correction	using	Bonferroni	
and	 Benjamini	 Hochberg	 methods	 (replicate	 analysis)	 were	 used	 for	 identifying	 differentially	 expressed	
genes	under	different	experimental	conditions.	log10	adjusted	p-values	and	log2	fold	changes	generated	by	
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these	 analyses	were	 plotted	 using	 R	 package	 pheatmap	 (version	 3.2.1)	 to	 create	 heatmaps.	 Genes	with	
normalized	 expression	 lower	 than	 6	 across	 all	 samples	were	 not	 expressed	 and	 thus	 removed	 from	 the	
analysis.	 Pathway	 analysis	 was	 performed	 with	 the	 DAVID	 (Database	 for	 Annotation,	 Visualization	 and	
Integrated	Discovery)	online	tool	(https://david.ncifcrf.gov/).	
Gene	ontology	analysis:	
Lists	of	 genes	were	analyzed	using	Panther	 tool	 (http://www.geneontology.org/)	and	 the	GO	Enrichment	
Analysis	to	create	a	gene	ontology	(GO).	GOs	with	p	values	<	0.0001	and	fold	enrichment	>	2	were	selected	
and	results	were	presented	according	to	their	-log10(p	value).	
	
Differentiation	of	bone	marrow-derived	macrophages:	
Isolation	 and	 differentiation	 of	 BMDMs	were	 performed	 as	 described	 earlier	 (Daniel,	 Balint	 et	 al.	 2014).	
Briefly,	 isolated	 bone	 marrow-	 derived	 cells	 were	 differentiated	 for	 6	 days	 in	 the	 presence	 of	 L929	
supernatant.		
	
ChIP	(Chromatin	immunoprecipitation):		
ChIP-qPCR	was	performed	essentially	as	previously	described	(Daniel,	Balint	et	al.	2014),	(Daniel,	Nagy	et	al.	
2014).	a-Bach1	antibody	was	a	gift	from	Dr	Spilianakis	(IMBB-FORTH,	Greece).		
	
Real-Time	Quantitative	PCR	for	enhancer	RNA	(qPCR):	
RNA	was	isolated	with	Trizol	reagent	(Ambion).	RNA	was	DNase-treated	and	reverse	transcribed	with	High-	
Capacity	 cDNA	 Reverse	 Transcription	 Kit	 (Applied	 Biosystems)	 according	 to	 manufacturer’s	 protocol.	
Transcript	 quantification	 was	 performed	 by	 qPCR	 reactions	 using	 SYBR	 green	 master	 mix	 (BioRad).	
Transcript	levels	were	normalized	to	Ppia	or	Actb.			
	
ATAC-seq:	
ATAC-seq	was	carried	out	as	described	earlier	with	minor	modification	(Buenrostro,	Giresi	et	al.	2013).	20	
000	cells	were	sorted	in	ice-cold	PBS.	Nuclei	were	isolated	with	ATAC-Lysis	Buffer	(10mM	Tris-HCl	pH7.4,	10	
mM	 NaCl,	 3	 mM	 MgCl2,	 0.1%	 IGEPAL)	 and	 were	 used	 for	 tagmentation	 using	 Nextera	 DNA	 Library	
Preparation	Kit	(Illumina)	from	2-3	biological	replicates.	After	tagmentation	DNA	was	purified	with	MinElute	
PCR	Purification	Kit	(Qiagen).	Tagmented	DNA	was	amplified	with	Kapa	Hifi	Hot	Start	Kit	(Kapa	Biosystems)	
using	 9	 PCR	 cycles.	 Amplified	 libraries	 were	 purified	 again	 with	MinElute	 PCR	 Purification	 Kit.	 Fragment	
distribution	 of	 libraries	 was	 assessed	with	 Agilent	 Bioanalyzer	 and	 libraries	 were	 sequenced	 on	 a	 HiSeq	
2500	platform.		
	
ATAC-seq	analysis:	
Two	 replicates	 of	 Ly6Chigh	 and	 low	 blood	monocytes,	muscle-derived	 Ly6Chigh	macrophages	 1	 day	 and	
Ly6Chigh	and	low	macrophages	2	and	4	days	upon	muscle	injury	were	used	for	the	ATAC-seq	experiments	
(20000	sorted	cells	per	 sample).	The	primary	analysis	of	ATAC-seq-derived	 raw	sequence	 reads	has	been	
carried	out	using	our	newest	version	of	ChIP-seq	analysis	command	line	pipeline	(Barta,	2011)	including	the	
following	steps:	Alignment	to	the	mm10	mouse	genome	assembly	was	done	by	the	BWA	tool	(Li	and	Durbin	
2009),	and	BAM	files	were	created	by	SAMTools	(Li,	Handsaker	et	al.	2009).	Signals	(peaks)	were	predicted	
by	 MACS2	 (Zhang,	 Liu	 et	 al.	 2008),	 and	 artifacts	 were	 removed	 according	 to	 the	 blacklist	 of	 ENCODE	
(ENCODE	Project	Consortium,	2012).	All	regions	derived	from	at	least	any	two	samples	were	united	within	
0.5kb	and	those	summits	having	the	highest	MACS2	peak	score	in	any	sample	were	assigned	to	each	region.	
Promoter-distal	 regions	 were	 selected	 excluding	 the	 TSS+/-0.5kb	 regions	 according	 to	 the	 mouse	
GRCm38.p1	 (mm10)	 annotation	 version.	 Tag	 directories	 used	 by	 HOMER	 in	 the	 following	 steps	 were	
generated	 with	 a	 120-nucleotide	 fragment	 length	 with	 makeTagDirectory	 (Heinz,	 Benner	 et	 al.	 2010).	
Genome	 coverage	 (bedgraph	 and	 tdf)	 files	 were	 generated	 by	 makeUCSCfile.pl	 (HOMER)	 and	 igvtools,	
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respectively,	and	used	for	visualization	with	IGV2	(Thorvaldsdottir,	Robinson	et	al.	2013).	Read	distribution	
(RD)	heat	maps	were	created	by	annotatePeaks.pl	 (HOMER),	went	through	an	upper	decile	normalization	
and	 were	 visualized	 by	 Java	 TreeView	 (Saldanha	 2004).	 10	 clusters	 of	 promoter-distal	 open	 chromatin	
regions	 were	 discriminated	 by	 K-means	 clustering	 based	 on	 the	 RD	 of	 all	 samples	 used.	 Dynamically	
changing	 clusters	 with	 similar	 profile	 but	 different	 density,	 were	 united.	 Motif	 enrichments	 for	 all	 10	
clusters	were	determined	by	 findMotifsGenome.pl	 (HOMER).	 Top	PU.1	 and	TRE	motif	 hits	 as	well	 as	 the	
MARE	 (mafa,	 mafk	 and	 bach1)	 motifs	 of	 HOMER’s	 motif	 collection	 were	 used	 to	 map	 the	 putative	
regulatory	 elements	 to	 each	 region	 around	 the	 chosen	 summits	 plotted	 in	 30-nucleotide	windows	 using	
annotatePeaks.pl	 (HOMER)	and	other	command	 line	programs	 including	 intersectBed	 (BEDtools)	 (Quinlan	
and	 Hall	 2010).	 TRE	 motif	 matches	 overlapping	 with	 MAREs	 were	 excluded	 from	 the	 analysis.	 Motif	
distribution	plots	were	visualized	by	Java	TreeView.	
	
Statistics:		
ANOVA	with	Bonferroni	correction	for	multiple	testing	was	used	to	determine	statistical	significance	using	
GraphPad	 Prism	 6.	 Adjusted	 p	 values	 (P<0.05=*,	 P<0.01=**,	 P<0.001=***,	 P<0.0001=****)	 are	 stated	
within	 figure	 legends	 and	 all	means	 are	 displayed	 ±	 SEM.	 For	 qRT-PCR	 analysis,	 three	biological	 samples	
were	used	for	each	condition.	For	FACS	marker	analysis,	four	independent	samples	were	analyzed.	At	least	
105	 cells	 were	 counted	 for	 FACS	 cell	 populations.	 For	 the	 histology	 experiments,	 at	 least	 10	 biological	
samples	were	used	(each	animal	provides	2	biological	samples).	
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Results	
	
Part	1.	Macrophage	gene	expression	profile	during	physiological	sterile	inflammation	and	tissue	repair.	
	
Cardiotoxin	induced	skeletal	muscle	damage	is	a	robust	model	of	immune	cell	assisted	regeneration.		
	
We	sought	to	understand	the	role	and	contribution	of	myeloid	cells,	primarily	macrophages	and	also	
their	 interactions	 during	 skeletal	muscle	 regeneration.	We	 chose	 the	 CTX	 induced	 skeletal	muscle	 injury	
model	 since	 this	 model	 proved	 to	 be	 instrumental	 for	 the	 identification	 of	 exogenous	 mechanisms	 of	
muscle	regeneration	but	it	is	also	suitable	to	study	the	effect	of	the	regenerating	muscle	upon	myeloid	cell	
activity.	The	model	works	as	 follows:	 	by	 injecting	cardiotoxin	 (snake	venom	peptide	 that	acts	as	protein	
kinase	C-specific	inhibitor)	intramuscularly,	we	induced	homogenous	skeletal	muscle	damage	in	the	Tibialis	
anterior	(TA)	muscles.	By	day	8	after	the	injury	the	overall	architecture	of	the	muscle	is	restored	although	
most	regenerated	myofibers	are	smaller	and	display	central	myonuclei,	a	known	hallmark	of	recent	muscle	
regeneration.	 Thus,	 any	 change	 in	 the	 cellular	 composition	 or	 altered	 histological	 features	 at	 day	 8	 post	
injury,	indicates	perturbations	in	intracellular	communications.	
	Upon	CTX	injury	a	large	number	of	circulating	immune	cells	infiltrate	and	accumulate	in	a	rapid	and	
highly	ordered	manner	inside	the	injured	tissue.	This	pool	of	invading	cells	consists	primarily	of	neutrophils,	
monocytes	 and	 macrophages.	 More	 specifically,	 after	 acute	 injury	 Ly6Chigh	 F4/80low	 monocytes	 infiltrate	
early	at	day	1	to	promote	the	clearance	of	necrotic	debris,	whereas	Ly6Clow	F4/80high	macrophages	emerge	
later	 through	 a	 phenotypic	 shift	 starting	 at	 day	 2	 and	 completed	 by	 day	 4,	 to	 assist	 tissue	 healing.	 The	
Ly6Chigh	and	Ly6Clow	macrophages	in	regenerating	muscle	display	distinct	inﬂammatory	proﬁles	than	those	
described	in	the	literature	 in	vitro	or	from	the	M1/M2	macrophage	subtype	classification	and	thus	cannot	
be	deﬁned	as	canonical	M1	or	M2	macrophages.	These	findings	support	the	notion	that	surface	markers	for	
macrophage	subsets	vary	depending	on	the	injury	model	and	tissue	they	are	extracted	from.		
	
Global	gene	expression	profile	of	muscle	macrophages	
	
To	extent	our	gene	expression	profiles	of	the	muscle	MFs,	we	performed	RNA-seq	analysis	on	the	
selected	populations	that	correspond	to	the	two	main	phases	of	inflammation	in	regenerating	muscle;	the	
pro-inflammatory	phase	(day	1-2),	followed	by	the	resolving/regenerative	phase	(day	4).	By	comparing	the	
gene	 expression	 profiles	 between	 the	macrophage	 subsets	 at	 each	 time	 point,	 we	 identified	 a	 series	 of	
novel	 molecules	 secreted	 by	 macrophages	 that	 could	 be	 involved	 in	 myogenesis.	 In	 addition,	 gene	
expression	 data	 showed	 good	 overlap	 with	 anticipated	 expression	 patterns	 of	 known	 regulators	 and	
effectors	of	muscle	regeneration.	These	results	indicated	that	an	unbiased	analysis	of	the	gene	expression	
patterns	using	RNA-seq	(with	higher	sensitivity	than	microarrays)	might	report	yet	unidentified	molecular	
mechanisms	 that	are	 relevant	 to	 the	acute	and	 resolution	phases	of	 the	 inflammation	within	 the	 injured	
muscle.	
	
Macrophage	Gdf15	regulates	skeletal	muscle	regeneration	by	activating	myoblast	proliferation	
	
Several	 strategies	were	 tested	 to	 analyze	 the	 kinetics	 of	 gene	 expression	 by	macrophage	 subsets	
during	the	time	course	of	muscle	regeneration.	We	found	that	the	"vertical"	comparison	between	Ly6Chigh	
and	Ly6Clow	macrophage	subsets	at	each	time	point	provided	the	most	robust	results.	Interestingly,	many	of	
the	 top-ranking	 genes	 in	 the	 list	 of	 genes	 that	 were	 upregulated	 at	 day	 2	 in	 the	 Ly6ChighF4/80low	 vs	
Ly6ClowF4/80high	populations,	was	enriched	with	genes	associated	with	 inflammation	 such	as	 Il1b,	Clec4e,	
Ccr2,	 Nfkb2,	 Cebpb	 in	 accordance	 with	 the	 role	 of	 Ly6Chigh	 macrophages	 in	 the	 mounting	 of	 the	
inflammatory	response	following	injury.	At	the	top	of	the	list,	an	extracellular	matrix	proteoglycan	named	
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versican	was	exclusively	expressed	 in	 Ly6ChighF4/80low	macrophages,	notably	 at	 the	 first	 stages	of	muscle	
regeneration.	These	results	indicated	that	macrophages	could	be	active	contributors	of	ECM	reorganization	
during	the	initial	phase	of	muscle	regeneration.		
Similarly,	many	of	the	top-ranking	genes	in	the	list	of	genes	that	were	upregulated	at	day	2	and	day	
4	in	the	Ly6ClowF4/80high	vs	Ly6ChighF4/80low	populations	were	enriched	with	genes	associated	with	mature	
macrophages	and	tissue	repair,	such	as	Igf1,	Myo1e,	CD36,	Cx3cr1,	Pparg,	Stat1,	Rxra,	Cebpa.	Among	these	
genes,	growth	differentiation	factor	15	was	upregulated	in	Ly6ClowF4/80high	macrophages	at	the	later	stages	
of	muscle	regeneration	at	Day	2	and	Day	4	respectively.	Based	on	these	unbiased	findings,	we	hypothesized	
that	Gdf15	could	potentially	influence	the	outcome	of	skeletal	muscle	regeneration	by	acting	as	an	effector	
on	the	muscle	tissue	itself.	To	test	this	hypothesis,	we	used	macrophage	deficient	(including	bone	marrow	
transplantations)	knock-out	strains	for	Gdf15.	These	2	models	exhibited	a	profound	impairment	in	muscle	
regeneration	and	clearly	indicated	that	that	these	genes	critically	contributed	to	muscle	regeneration.		
Since	Gdf15	is	a	growth	factor	we	wanted	to	characterize	the	GDF15	effector	function,	and	thus	we	
cultured	primary	myoblasts	with	or	without	recombinant	GDF15.	We	found	that	addition	of	rGDF15	to	the	
culture	 medium,	 significantly	 increased	 myoblast	 proliferation.	 We	 also	 examined	 the	 dynamics	 and	
composition	of	 immune	 infiltration	 in	 injured	muscle	 in	WT	and	Gdf15	KO	animals	 and	 found	 that	more	
myeloid	cells	 infiltrated	the	 injured	muscle	 in	Gdf15	KO	animals	at	day	2	and	4	post	CTX.	 In	addition,	we	
detected	significant	differences	in	the	subset	composition	of	infiltrating	MFs	at	day	2	and	4	after	CTX	injury.	
Collectively,	 these	 results	 show	 that	 Gdf15	 deficiency	 affects	 both	 myeloid	 cells	 infiltration	 and	
differentiation	within	the	regenerating	muscle.	
	
Macrophage	 PPARg	 regulates	 cell	 type	 specific	 genes	 in	 muscle	 infiltrating	 MFs	 and	 skeletal	 muscle	
regeneration	
	
Recent	reports	suggested	cell	metabolism	as	a	defining	factor	in	MFs	identity	and	functional	status.	
When	 analyzing	 the	 RNA-seq	 expression	 data	 for	 metabolic	 regulators	 that	 could	 account	 for	 such	 a	
preference	for	metabolic	genes,	we	found	that	a	master	regulator	of	metabolism,	Pparg,	was	expressed	at	a	
high	level	in	the	Ly6Clow	repair	subset.	Based	on	this	finding,	we	hypothesized	that	MF	PPARg	is	a	metabolic	
sensor	and	regulator	of	 skeletal	muscle	 regeneration.	By	using	 two	distinct	genetic	knock-out	models	we	
clearly	show	that	PPARg	activity	in	muscle	infiltrative	MFs,	critically	contributed	to	the	timely	resolution	of	
inflammation	and	eventually	to	skeletal	muscle	regeneration.	
As	only	few	paracrine	signaling	pathways	between	MFs	and	tissue	progenitors	have	been	described,	
we	 decided	 to	 pursue	 the	 identification	 of	 the	 putative	 regulatory	 circuit	 that	 might	 connect	 muscle	
infiltrating	 MFs	 to	 myotube	 differentiation	 in	 a	 PPARg	 dependent	 manner.	 As	 PPARg	 is	 a	 transcription	
factor,	we	presumed	that	a	relevant	change	in	the	gene	expression	in	muscle	MFs	must	shed	light	on	the	
regulatory	 circuit	 that	 is	 abrogated	 in	 PPARg	 KO	 MFs.	 To	 identify	 PPARg	 dependent	 gene	 expression	
changes	in	muscle	infiltrating	MFs,	we	isolated	representative	populations	of	MFs	from	regenerating	muscle	
(Day	1,	2	and	4	post	CTX)	from	WT	and	PPARg	MacKO	animals	and	analyzed	their	gene	expression	profiles	
by	microarrays.	We	were	looking	for	genes	that	(1)	were	PPARg	dependent	in	more	than	one	MF	subset,	(2)	
coded	a	secreted	factor	and	(3)	whose	activity	might	be	linked	to	muscle	differentiation	based	on	existing	
data.	 Strikingly,	 there	 was	 only	 1	 gene,	 namely	 Growth	 differentiation	 factor	 3	 (Gdf3),	 that	 fit	 all	 these	
criteria	and	was	consistently	downregulated	in	all	4	investigated	MF	populations.	
	
Macrophage	GDF3	regulates	myoblast	differentiation	and	muscle	regeneration	
	
GDF3	 belongs	 to	 the	 TGFβ	 family,	 whose	 members	 are	 secreted	 factors	 acting	 in	 a	 paracrine	
manner.	Several	members	of	the	TGFβ	family	are	known	regulators	of	muscle	regeneration,	including	GDF8	
(also	 known	 as	Myostatin).	 Therefore,	 we	 selected	 Gdf3	 as	 the	most	 likely	 PPARg	 dependent	 gene	 that	
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contributes	 to	muscle	 regeneration	 for	 further	analysis.	 In	WT	animals,	 the	protein	expression	 showed	a	
pronounced	 induction,	 which	 peaked	 at	 day	 4,	 a	 time	 when	 inflammation	 subsides	 and	 regenerative	
processes	 start	 to	 dominate	within	 the	 injured	muscle.	 In	 the	 PPARg	deficient	 and	Gdf3	 KO	 animals	 this	
induction	 is	 lost,	 contributing	 to	 muscle	 regeneration	 delay.	 Exogenously	 added	 GDF3	 rescued	 the	
regeneration	 deficit	 seen	 in	 these	 animals	 underlining	 the	 importance	 of	 MF	 derived	 GDF3	 in	 skeletal	
muscle	regeneration.	In	addition,	it	validated	our	hypothesis	regarding	the	existence	of	a	PPARg-GDF3	axis	
responsible	for	the	regulation	of	tissue	regeneration.	To	characterize	GDF3’s	effector	function,	we	cultured	
primary	 myoblasts	 with	 or	 without	 recombinant	 GDF3.	We	 found	 that	 addition	 of	 GDF3	 to	 the	 culture	
medium	induced	a	robust	effect	of	GDF3	on	myotube	formation	suggesting	that	GDF3,	once	released	from	
MFs	within	 the	 injured/regenerating	 tissues,	could	 regulate	molecular	pathways	 relevant	 to	 the	 fusion	of	
differentiating	muscle	cells.		
	
GDF3	restores	muscle	regeneration	in	aged	mice	
	
Skeletal	muscle	mass,	 function,	and	 repair	 capacity	all	progressively	decline	with	aging,	 restricting	
mobility,	 voluntary	 function,	and	quality	of	 life.	The	PPARg-GDF3	 regulatory	axis	described	 in	our	 studies	
identifies	 a	 sensory-regulatory-effector	 mechanism,	 by	 which	MFs	 are	 regulators	 of	 the	 skeletal	 muscle	
progenitor	 compartment.	This	axis	orchestrates	 tissue	 regeneration,	and	 let	us	 to	hypothesize	 that	GDF3	
expression	might	be	 impaired	 in	geriatric	mice	 (28-month-old),	 and	a	potential	 alteration	of	 the	 immune	
response	with	 aging	 is	 also	 a	muscle	 regeneration	disturbing	 factor,	 due	 to	 its	 role	 in	 the	 stimulation	of	
satellite	cell	proliferation	and	differentiation.	Indeed,	by	infusing	rGDF3	intramuscularly,	we	restore	the	old	
muscles	ability	to	regenerate,	through	proper	activation	of	satellite	cells.	These	results	highlight	that	GDF3	
is	 able	 to	modulate	muscle-resident	 cells,	 and	possibly	 immune	and	muscle	 cell	 cross-talk	 during	muscle	
repair	in	a	geriatric	model	of	impaired	regeneration.		
	
Part	2.	Chromatin	dynamics	of	macrophages	during	muscle	regeneration	
	
MARE	binding	TFs	remodel	the	muscle	related	macrophage	genome	
	
During	 the	next	phase	of	our	studies	we	were	 interested	 in	what	kind	of	epigenomic	changes	are	
taking	 place	 during	 macrophage	 subtype	 specification	 following	 acute	 sterile	 injury	 by	 CTX.	 We	
hypothesized	 that	 by	 using	 an	 unbiased	 genomic	 approach	 called	 “assay	 for	 transposase	 accessible	
chromatin”	 (ATAC-seq),	we	 could	 study	 the	 chromatin	 structure	and	accessibility	during	 the	 transition	of	
inflammatory	macrophages	to	repair	type	ones,	and	thus	identify	novel	regulators	of	this	process.	ATAC-seq	
experiments	 revealed	 a	 dynamic	 and	 dramatically	 reorganized	 chromatin	 structure,	 affecting	 both	
inflammatory	and	repair	related	marker	gene	loci	(Arg1,	Il1b,	Klf4,	Cd68,	Slc40a1,	Il1r2,	Tgfbr1,	Cd80,	Nfkb1,	
Mcl1,	 Il10,	 Igf1,	 Ptges).	 Using	 de	 novo	 motif	 analysis,	 we	 could	 detect	 and	 identify	 sequence	 motifs	
associated	 with	 the	 unique	 chromatin	 regions	 changing	 during	 the	 macrophage	 phenotypic	 transition,	
informing	us	about	the	binding	sites	of	potential	transcriptional	regulators.	Surprisingly	regions	that	close	
showed	more	enrichment	for	PU.1	motifs,	while	on	the	other	hand	we	found	that	the	TRE	and	MARE	motifs	
were	 enriched	 at	 the	 opening	 sites.	MARE	 binding	 TFs	 have	 never	 been	 described	 or	 implicated	 in	 such	
dynamic	chromatin	changes	and	only	2	members	of	the	MARE	binding	TF	family	are	differentially	expressed	
(BACH1	and	NFE2L2),	in	inflammatory	Ly6Chigh	vs	repair	Ly6Clow	macrophages,	suggesting	that	these	two	TFs	
are	activated	 in	macrophages	as	part	of	 the	wound	 response.	 In	 summary,	our	unbiased	approach	using	
ATAC-seq	 identified	 the	 presumed	 TFs	who	might	 be	 relevant	 in	macrophage	 phenotypic	 transition	 and	
showed	the	dynamic	nature	of	the	regeneration	process	with	regards	to	changes	at	the	chromatin	level.	
	
Hmox1	is	a	direct	target	gene	of	Bach1,	driven	by	a	damage	response	specific	enhancer	cluster	
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Transcription	 factors	 can	 be	 categorized	 on	 the	 basis	 of	 their	 effect	 on	 gene	 expression.	
Transcriptional	 activators	 like	 NFE2L2	 (Nuclear	 Factor,	 Erythroid	 2	 Like	 2)	 promote	 gene	 expression	 and	
have	 signal-dependent	 activity.	 Transcriptional	 repressors	 like	BACH1	 (BTB	Domain	And	CNC	Homolog	1)	
inhibit	gene	expression	driven	by	transcriptional	activators	and	therefore	function	to	oppose	or	shape	their	
functional	 outcome.	 Therefore,	 to	 understand	 the	 function	 of	 transcriptional	 activators,	 it	 is	 essential	 to	
consider	 the	 transcriptional	 repressors	 that	 they	 antagonize.	 Moreover,	 as	 the	 process	 of	 cellular	
differentiation	 requires	 both	 activation	of	 lineage-specific	 gene	expression	programs,	 and	 suppression	of	
alternative	 lineage	 gene	expression	programs,	 it	 is	 important	 to	 consider	 the	 functions	of	 transcriptional	
repressors	in	the	context	of	the	alternative	lineage	programs	that	they	antagonize.		
As	 an	 example	 of	 data	 integration,	 the	 MARE	 binding	 transcriptional	 repressor	 BACH1	 is	 highly	
expressed	 and	 overrepresented	 in	 Ly6Chigh	 inflammatory	 macrophages	 while	 its	 binding	 motif	 is	
unexpectedly	 enriched	 specifically	 in	 the	 open	 chromatin	 regions.	 BACH1	 is	 a	 basic	 leucine	 zipper	 (bZIP)	
protein	that	is	released	from	the	chromatin	in	response	to	cell	injury	and	inflammation,	and	as	an	end	result	
a	 significant	 increase	 in	 the	 expression	 of	 antioxidant	 proteins,	 such	 as	 heme	 oxygenase	 1	 (HMOX1),	 an	
enzyme	 crucial	 for	 toxic	 heme	 clearance,	 is	 observed.	 Analysis	 of	 the	Hmox1	 locus	 using	 ATAC-seq	 data	
visualization,	 BACH1	 chromatin	 immunoprecipitation	 (ChIP)	 and	 enhancer	 RNA	 qPCR	 measurements	
identified	 novel	 regulatory	 elements,	 showing	 extensively	 transcribed	 enhancer	 regions	 spanning	 12kb	
upstream	of	Hmox1	transcription	start	site	(TSS).	 In	addition,	a	gene	enrichment	analysis	on	our	RNA-seq	
data	from	CTX	injured	muscle	infiltrating	macrophages,	revealed	that	iron	and	heme	related	pathways	are	
being	 enriched	 in	 the	 Ly6Clow	 repair	macrophages,	 further	 suggesting	 that	 the	 heme-BACH1-HMOX1	 axis	
could	have	a	crucial	role	in	the	inflammatory	response	and	muscle	regeneration	outcome	after	CTX	injury.	
	
Heme-Bach1-Hmox1	axis	is	required	for	efficient	muscle	regeneration	
	
Searching	for	the	functional	role	of	Bach1,	Hmox1	and	heme	during	muscle	regeneration	we	used	
our	 CTX	 injury	 model	 and	 utilized	 in	 vivo	 heme	 treatments,	 Bach1	 KO	 animals	 (including	 bone	 marrow	
transplantation	to	assess	myeloid	Bach1)	and	myeloid	specific	Hmox1	KO	mice.	Notably,	Bach1	KO	serves	
also	as	genetic	model	of	Hmox1	overexpression,	while	 in	vivo	heme	treatments	serves	both	as	a	transient	
BACH1	knock-down	model	and	consequently	a	HMOX1	overexpression	model.	In	all	3	experimental	models	
muscle	regeneration	was	severely	impaired	at	day	8	post	CTX.	Intriguingly,	the	regeneration	process	in	the	
Bach1	 KO	 is	 still	 impaired	 even	 at	 later	 stages	 (day	 21	 and	 day	 70	 post	 CTX)	 while	 no	 developmental	
impairment	was	observed	in	Bach1	KO	uninjured	muscles	suggesting	that	the	muscle	regeneration/growth	
impairment	is	only	evident	after	an	acute	injury.		
	
Heme-Bach1-Hmox1	axis	controls	the	phenotypic	transition	of	myeloid	cells	following	CTX	injury	
	
Next,	we	asked	whether	 the	 impaired	muscle	 regeneration	was	caused	by	a	defect	 in	 the	cellular	
dynamics	 of	 the	 myeloid	 cell	 infiltrate	 during	 muscle	 regeneration.	 Interestingly,	 we	 did	 not	 find	 any	
difference	 in	 the	 numbers	 of	 invading	 myeloid	 cells	 (CD45+)	 at	 any	 of	 timepoints	 we	 examined,	 thus	
excluding	 the	 possibility	 of	 a	 massively	 diminished	 myeloid	 cell	 invasion	 contributing	 to	 the	 muscle	
regeneration	impairment	we	observed	previously.	However,	this	finding	did	not	exclude	the	possibility	of	a	
change	 in	 the	cellular	composition	and	differentiation	of	 the	 infiltrating	myeloid	cells.	Surprisingly,	 in	 the	
case	of	Hmox1fl/fl	LysMCre	muscles,	the	phenotypic	shift	is	severely	delayed	while,	in	the	case	of	Bach1	KO	
and	heme	treated	muscles,	the	ratio	of	Ly6Clow	is	higher.		In	summary,	we	observe	significant	differences	in	
the	ratios	of	inflammatory	and	repair	macrophages,	during	their	phenotypic	transition	suggesting	a	critical	
role	for	heme,	BACH1	and	HMOX1	in	response	to	the	acute	sterile	injury,	showing	that	they	function	as	a	
switch	between	inflammatory	(Ly6Chigh)	to	repair	macrophages	(Ly6Clow).	
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Muscle	regeneration	related	genes	are	novel	Bach1	targets	and	contribute	to	the	impaired	muscle	repair	
phenotype	
	
Evaluation	 of	 gene	 expression	 data	 from	 Bach1	 KO	 muscle	 infiltrating	 macrophages	 revealed	
dysregulation	of	 numerous	 genes	 (Il6,	 Il10,	Dusp1,	 Slc40a1,	 Cebpb,	Gdf3,	 Igf1,	 Pparg)	 involved	 in	muscle	
regeneration	 and	 macrophage	 phenotype	 switching,	 suggesting	 that	 Bach1	 potentially	 controls	 the	
expression	 of	 these	 important	 genes	 by	 regulating	 their	 enhancers.	 To	 validate	 these	 observations,	 we	
performed	BACH1	ChIP	experiments	 in	BMDMs	before	and	after	heme	treatment	and	demonstrated	that	
BACH1	 is	bound	at	multiple	enhancers,	at	various	genomic	 locations	and	distances	 from	the	TSS	of	 these	
genes.	 This	 suggests	 that	 BACH1	directly	 binds	 and	 regulates	 important	 inflammatory	 and	 repair	 related	
genes	 in	 the	context	of	muscle	 regeneration	 (such	as	 Igf1,	 Slc40a1,	 Il6,	 Il10,	Gdf3,	Pparg,	Dusp1,	Cebpb),	
which	further	explains	the	severity	of	the	Bach1	KO	delayed	muscle	regeneration	phenotype.	In	summary,	
we	 show	 that	 Bach1	 is	 an	 acute	 damage	 signal	 dependent	 TF	 having	 a	 much	 larger	 gene	 regulation	
repertoire	that	expands	beyond	iron	and	heme	related	pathways.	
	
Part	3.	Reciprocal	satellite-myeloid	cell	communication	during	regeneration.	
	
Aside	from	the	transcriptional	regulation	of	muscle	infiltrating	macrophages	that	we	studied	so	far,	
we	wanted	to	identify	what	are	the	cell	interactions	within	the	injured	tissue	cell	milieu	that	contribute	or	
potentially	control	the	macrophage	phenotypic	switch.	Here,	by	using	the	cardiotoxin	(CTX)	induced	skeletal	
muscle	injury	combined	with	(1)	irradiation	as	a	means	to	alter	cellular	composition	prior	to	injury,	(2)	bone	
marrow	 transplantation	 to	 replenish	 myeloid	 cells,	 (3)	 in	 vivo	 imaging	 to	 monitor	 the	 myeloid	 cell	
phenotypic	switch	 in	situ,	and	 (4)	 focusing	on	 in	vivo	ablation	of	a	specific	muscle	cell	population	 (paired	
box	 7	 (PAX7)	 positive	 cells)	 as	 a	 proof	 of	 concept,	we	 tried	 to	 show	 that	muscle	 tissue	 integrity	 and	 cell	
composition	prior	 to	 the	 injury	 is	 required	 for	 in	 situ	macrophage	phenotypic	 shift	 and	 subsequently	 for	
proper	and	complete	tissue	regeneration.		
	
The	satellite	cell	pool	is	radiation	sensitive	and	is	required	for	proper	muscle	regeneration.	
	
We	first	sought	to	validate	whether	muscle	regeneration	 is	 indeed	 impaired	 in	 irradiated	muscles,	
and	second	whether	this	effect	is	due	to	diminished	satellite	cell	populations.	Indeed,	muscle	regeneration	
in	 the	 irradiated	 muscles	 is	 severely	 impaired,	 even	 after	 2	 months	 post	 irradiation,	 in	 comparison	 to	
control	non-irradiated	or	radioprotected	muscles.	To	assess	the	effect	of	irradiation	on	the	local	muscle	cell	
pool	and	more	specifically	on	satellite	cell	pool,	we	measured	the	mRNA	expression	of	a	commonly	used	
marker;	Pax7	via	qPCR	and	validated	PAX7	expression	through	immunohistochemistry.	Our	data	show	that	
indeed	 Pax7	 mRNA	 expression	 is	 decreased	 in	 the	 irradiated	 muscles	 compared	 to	 controls	 and	
radioprotected	muscles	at	8	weeks	following	irradiation.	Interestingly,	this	effect	is	evident	in	both	injured	
(Day	 8	 post	 CTX)	 and	 uninjured	 irradiated	 muscles	 (Day	 0).	 Furthermore,	 PAX7	 staining	 revealed	 fewer	
PAX7+	 cells	 in	 the	 irradiated	muscles	 both	 at	 day	 0	 and	 day	 8	 post	 CTX	 injury.	 Radioprotected	muscles	
served	 as	 control	 and	 showed	 similar	 numbers	 of	 PAX7+	 cells	 to	 non-irradiated	 control	 muscles.	 These	
results	suggest	that	PAX7+	satellite	cells	are	indeed	radiosensitive	and	are	likely	to	be	the	major	cause	of	the	
muscle	regeneration	deficiency	observed	in	irradiated	muscles.	
	
Delayed	phenotypic	transition	of	myeloid	cells	in	irradiated	muscles	following	CTX	injury	
	
Next,	we	asked	whether	the	impaired	muscle	integrity,	and	the	altered	cellular	composition	induced	
by	 irradiation	prior	to	an	acute	 injury,	would	have	any	effect	on	the	cellular	dynamics	of	the	myeloid	cell	
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infiltrate	 during	 muscle	 regeneration	 (even	 after	 2	 months	 post	 irradiation).	 Interestingly,	 we	 found	 a	
statistically	 significant	 increase	 in	 the	 numbers	 of	 invading	myeloid	 cells	 (CD45+)	 in	 the	 irradiated	 versus	
radioprotected	muscles	at	both	timepoints	thus	excluding	the	possibility	of	a	massively	diminished	myeloid	
cell	 invasion	contributing	 to	 the	muscle	 regeneration	 impairment	we	observed.	However,	 this	 finding	did	
not	 exclude	 the	 possibility	 of	 a	 change	 in	 the	 cellular	 composition	 and	 differentiation	 of	 the	 infiltrating	
myeloid	 cells.	 Surprisingly,	 in	 the	 case	of	 irradiated	muscles,	 the	phenotypic	 transition	 starts	 later	 and	 is	
completed	 only	 by	 day	 6	 (normal	 phenotypic	 shift	 dynamics	 are	 completed	 by	 day	 4).	 In	 summary,	 we	
observe	a	remarkably	long	2-day	delay	(in	the	context	of	an	8-day	regeneration	process)	in	the	phenotypic	
transition	 of	 infiltrating	 myeloid	 cells	 in	 the	 irradiated	 muscles.	 In	 addition,	 it	 also	 showed	 that	
radioprotection	 (in	 the	 form	of	 lead	shielding)	during	 irradiation	exposure	prevented	the	delay	of	muscle	
regeneration	following	CTX	injury,	by	preserving	the	local	muscle	cell	composition	and	by	maintaining	the	
infiltrating	myeloid	cell	kinetics.	However,	we	reached	the	 limit	of	this	method	because	we	are	unable	to	
differentiate	between	the	BM-derived	and	the	tissue	resident	macrophages	as	the	source	of	the	infiltration.		
	
Bone	marrow	transplantation	allows	establishing	the	source	of	myeloid	cell	invasion	and	phenotypic	shift	
	
In	order	 to	 control	 the	 source	of	 the	 infiltrating	 cells	 (BM-derived),	 and	 to	exclude	 the	possibility	
that	the	restoration	of	the	 infiltration	dynamics	 in	the	radioprotected	muscles	 is	due	to	the	protection	of	
the	resident	tissue	macrophages,	we	performed	bone	marrow	transplantation	(BMT).	This	method	allowed	
us	 to	 investigate	whether	 the	 infiltrating	myeloid	cells	 in	both	 the	 radioprotected	and	 irradiated	muscles	
share	 the	 same	 features,	 and	 originate	 from	 the	 donor	 C57BL/6J	 bone	 marrow	 (CD45.2	 positive).	 It	 is	
important	 to	 note	 that	 total	 body	 irradiation	 precedes	 BMT	 thus	 giving	 us	 the	 unique	 opportunity	 to	
combine	 irradiation	 induced	cell	ablation	and	myeloid	cell	 tracing.	 In	agreement	with	our	previous	 lower	
body	irradiation	experiments,	muscle	regeneration	in	these	BMT	animals	is	severely	impaired,	even	after	2	
months	post	irradiation	and	BMT,	in	comparison	to	control	non-BMT	animals.	In	addition,	when	we	further	
followed	up	the	regeneration	period	 in	the	BMT	animals	we	observed	that	recovery	to	a	morphologically	
and	histochemically	mature	muscle	takes	at	 least	2	more	weeks	(Day	20	post	CTX)	compared	to	the	non-
BMT.	Furthermore,	we	did	not	find	any	statistically	significant	differences	between	the	numbers	of	invading	
myeloid	 cells	 (CD45+)	 in	 BMT	 versus	 non-BMT	 controls	 validating	 our	 previous	 results.	 Examining	 the	
dynamics	 of	 the	 infiltrating	myeloid	 cell	 populations	 during	 the	 course	 of	 the	 regeneration	 in	 non-BMT	
controls	 and	 BMT	 animals,	 we	 consistently	 observe	 a	 2-day	 delay	 in	 the	 phenotypic	 transition	 of	 the	
infiltrating	myeloid	cells	from	inflammatory	to	the	repair	phenotype.	These	experiments	reported	to	us,	as	
expected,	 that	 irradiation	 is	 impacting	 regeneration	 in	 the	 bone	marrow	 transplantation	model	 as	 well,	
while	we	can	readily	assess	the	origin	of	the	myeloid	infiltration.		
	
Local	 radioprotection	 during	 BMT	 allows	 the	 assessment	 of	 donor	 bone	 marrow	 derived	 invading	
macrophages	in	an	intact	muscle	tissue	environment	
	
The	next	obvious	question	was	to	determine	whether	radioprotection	(lead	shielding)	 in	the	BMT-
shielded	animals	sustains	the	cellular	dynamics	of	the	myeloid	cell	invasion	following	CTX	injury	at	control	
levels.	 Indeed,	 radioprotection	 by	 lead	 shielding	 effectively	 attenuated	 radiation	 effects	 and	 protected	
muscle	tissue	integrity.	 In	addition,	to	prove	that	the	infiltrating	cells	 in	both	the	BMT-shielded	and	BMT-
unshielded	muscles	originate	from	the	donor	C57BL/6J	bone	marrow	(CD45.2	positive)	and	share	the	same	
features,	 we	 quantified	 CD45+	 positive	 cells	 according	 to	 the	myeloid	 lineage	markers	 CD45.1	 (recipient	
BoyJ	 bone	 marrow	 stains	 positive	 for	 CD45.1	 but	 not	 CD45.2)	 and	 CD45.2	 by	 FACS.	 Over	 90%	 of	 the	
infiltrating	 cells	 in	both	 the	BMT-shielded	and	BMT-unshielded	muscles	were	CD45.2	positive	which	 is	 in	
line	 with	 the	 level	 of	 chimerism	 detected	 in	 the	 blood	 from	 the	 same	 animals,	 thus	 excluding	 the	
contributions	of	tissue	resident	macrophages	in	the	observed	phenotype.	By	demonstrating	that	the	donor-
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derived	cells	infiltrate	(CD45.1	vs.	CD45.2	%)	is	present,	even	when	the	host	limb	is	radioprotected	during	
BMT;	suggest	that	this	BMT	modification	could	be	a	viable	model	for	muscle	regeneration	studies	despite	
the	tibia	and	femur	not	being	irradiated.	Taken	together,	these	results	suggest	that	the	cause	of	the	delay	in	
regeneration	is	the	effect	of	 irradiation	of	the	leg	itself	and	not	elsewhere	in	the	body	for	example	in	the	
bone	marrow,	blood	or	spleen	that	are	sites	where	myeloid	cells	could	be	derived	from.	
	
18F-FDG	 PET-MRI	 allows	 in	 vivo	 monitoring	 of	 the	 infiltrating	 immune	 response	 and	 reveals	 that	 the	
invading	myeloid	cells	are	metabolically	distinct	
	
The	 analysis	 of	myeloid	 cells	 following	 the	 injury	 based	 on	 surface	markers	 requires	 long	 (over	 6	
hours)	and	tedious	tissue	processing.	In	order	to	obtain	additional	and	truly	in	vivo	non-invasive	reading	of	
myeloid	cell	invasion	we	turned	to	in	vivo	imaging.	Positron	Emission	Tomography	(PET)	imaging	technique	
is	a	widely	used	noninvasive	method	in	clinical	and	preclinical	studies	for	the	detection	of	tumors,	staging	
and	monitoring	the	effect	of	cancer	therapy.	Glucose	analogue,	2-[18F]	fluoro-2-deoxy-d-glucose	(18F-FDG)	is	
the	most	commonly	used	and	validated	tracer,	which	is	up	taken	by	activated	cells	where	it	is	metabolically	
trapped	and	accumulates	 in	proportion	 to	 intracellular	 demands.	 Increased	 FDG	uptake	was	observed	 in	
several	 energy-intensive	 processes,	 such	 as	 infections	 and	 inflammation	 and	 has	 been	 associated	 with	
activated	neutrophils	and	macrophages,	 so	we	hypothesized	 that	using	FDG	as	a	 tracer	and	combining	 it	
with	MRI,	could	be	a	novel	and	effective	method	to	monitor	the	events	following	the	acute	muscle	injury	
and	 specifically	 the	 metabolism	 of	 the	 immune	 cells	 during	 the	 inflammatory	 response.	 The	 18F-FDG	
accumulation	was	overall	significantly	higher	in	the	injured	TA	muscle	area	in	all	the	timepoints	we	checked,	
compared	to	control	uninjured	animals.	We	next	asked	whether	the	signal	comes	from	the	muscle	resident	
cells	 or	 the	 infiltrating	 immune	 cells.	 To	 tackle	 this	 question,	we	 decided	 to	 perform	 an	ex	 vivo	 18F-FDG	
uptake	 on	 isolated	 myeloid	 CD45+	 versus	 non-myeloid	 CD45-	 cells	 from	 D1	 and	 D2	 injured	 muscles.	 In	
accordance	with	our	hypothesis	myeloid	CD45+	cells	seem	to	uptake	and	utilize	more	18F-FDG	compared	to	
non-myeloid	CD45-	cells,	which	is	line	with	previous	observations,	where	macrophages	co-localize	with	the	
in	vivo	PET	signal	in	inflamed	tissues.		
In	 summary,	 we	 demonstrated	 that	 18F-FDG	 PET-MRI	 is	 a	 valuable	 tool	 to	 monitor	 immune	 cell	
invasion	 in	 vivo.	 	 Thus,	 we	 used	 it	 in	 order	 to	 delineate	 and	 further	 explain	 the	 difference	 in	 the	
regeneration	process	between	BMT-shielded	and	BMT-unshielded	muscles.	More	specifically	we	detected	a	
significantly	lower	accumulation	of	18F-FDG	in	the	BMT-unshielded	muscles	compared	to	the	BMT-shielded	
muscles	of	the	same	animal	at	Day	2,	Day	4,	Day	5	and	Day	6	post	CTX.		
	
In	vivo	ablation	of	Pax7+	cells	produces	similar	phenotypic	transition	delay	on	infiltrating	macrophages.	
	
The	radioprotection	and	 in	vivo	 imaging	experiments	presented	 in	this	dissertation	suggested	that	
the	infiltrating	immune	response	of	skeletal	muscle	regeneration	is	regulated	by	a	local	radiosensitive	tissue	
compartment,	including	PAX7+	satellite	cells.	In	order	to	determine	if	the	decrease	in	satellite	cell	numbers	
observed	 following	 radiation	 is	 contributing	 to	 delayed	 macrophage	 phenotypic	 shift,	 we	 decided	 to	
deplete	satellite	cells	in	vivo	before	the	injury.	By	using	a	transgenic	mouse	model	for	selective	diphtheria	
toxin-induced	depletion	of	PAX7+	satellite	cells	we	observed	that	satellite	cell	ablation	(Pax7	CreER-DTA),	led	
to	alterations	not	only	 in	muscle	macrophage	 infiltration	numbers	both	at	Day	4	and	Day	6	post	CTX	but	
also	in	dynamic	MFs	phenotype	shift,	similar	to	irradiated	and	BMT-unshielded	muscles.	Therefore,	our	data	
suggest	that	it	is	indeed	Pax7-lineage	cell	pool,	which	is	regulating,	at	least	in	part,	the	repair	macrophage	
phenotype	transition.	Taken	together,	our	data	reveal	the	existence	of	a	reciprocal	cross	talk	between	the	
skeletal	 muscle	 tissue	 and	 myeloid	 cells	 recruited	 following	 the	 injury	 and	 establish	 an	 experimental	
paradigm	suitable	to	dissect	the	components	of	immune	cell	invasion	assisted	tissue	repair.	
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Discussion		
	
Inflammation	triggers	a	broad	array	of	physiological	and	pathological	processes	and	was	evolved	as	
a	response	to	restore	homeostasis.	Although	the	pathological	features	of	many	types	of	inflammation	are	
well	 understood,	 their	 physiological	 functions	 are	 mostly	 unknown.	 Thus,	 in	 order	 to	 develop	 specific	
therapeutic	 interventions	 of	 tissue	 malfunction	 or	 homeostatic	 imbalance	 (caused	 by	 dysregulated	
inflammation),	the	origins	and	physiological	features	of	an	inflammatory	response	need	to	be	understood	in	
a	 broader	 physiological	 context.	 The	 cardiotoxin	 (CTX)	 induced	 skeletal	 muscle	 injury	 model	 is	 an	 ideal	
experimental	 system	 to	 study	 physiological	 inflammation	 dynamics	 and	 tissue	 environment	 dependent	
monocyte-to-effector	macrophage	 transition	 processes.	 This	model	 induces	 a	 synchronous	 inflammation	
process	 allowing	 the	 isolation	of	 homogenous	 cell	 populations.	Upon	 injury,	 circulating	monocytes	 enter	
the	damaged	tissue	area	and	differentiate	to	macrophages	with	an	inflammatory	phenotype	(Ly6Chigh)	and	
that	 very	 fast	 (within	 1-2	 days)	 the	 same	 cells	 shift	 to	 a	 Ly6Clow	 repair	 macrophage	 phenotype	 (Varga,	
Mounier	et	al.	2013).	The	present	work	reveals	unexpected	highly	dynamic	changes	of	gene	expression	by	
macrophage	 populations	 during	 acute	 inflammation	 and	 subsequent	 tissue	 repair,	 confirming	 the	 highly	
versatile	 nature	 of	 these	 cells	 that	 can	 hardly	 be	 addressed	 in	 vitro.	 We	 show	 that	 macrophages	 from	
regenerating	 muscle	 are	 distinct	 from	 resting	 macrophages	 in	 other	 tissues,	 while	 they	 still	 are	 true	
macrophages.	 Unbiased	 analysis	 of	 gene	 expression	 by	 macrophage	 populations	 during	 muscle	
regeneration	revealed	that	time	segregation,	much	more	then	Ly6C	status	segregation	showed	the	highest	
differential	gene	expression.	Thus,	the	time	course	of	inflammation	is	the	predominant	organizing	force	in	
gene	expression	by	macrophages,	with	an	important	time	point	at	day	2-4	post	injury,	which	corresponds	to	
the	 full	 skewing	 of	 macrophages	 from	 Ly6Chigh	 to	 Ly6Clow	 status	 and	 the	 starting	 of	 resolution	 of	
inflammation.		
Several	groups	have	independently	showed	that	Ly6Chigh	macrophages	express	higher	levels	of	pro-
inflammatory	 cytokines	 (IL-1β,	 TNFα)	 and	 lower	 levels	 of	 anti-inflammatory	 cytokines	 (TGFβ,	 IL-10)	 than	
Ly6Clow	macrophages.	Therefore,	 these	macrophage	subsets	were	 identified	as	M1	and	M2	macrophages,	
respectively,	 to	 parallel	 the	 expression	 of	 these	 cytokines	 by	 in	 vitro	 LPS/IFNγ	 and	 IL-4	 activated	
macrophages,	 respectively.	 The	 data	 presented	 here	 show	 that	 although	 Ly6Chigh	 macrophages	
preferentially	expressed	pro-inflammatory	markers	and	Ly6Clow	macrophages	preferentially	expressed	anti-
inflammatory	markers,	the	differences	are	not	large,	despite	the	limitation	of	global	RNA	analysis	and	the	
fact	 that	 low	change	 in	mRNA	expression	may	 lead	to	big	changes	 in	 function	at	 the	protein	 level.	These	
results	 indicate	 that	 in	 vivo,	 macrophages	 cannot	 be	 restricted	 and	 defined	 according	 to	 the	 M1/M2	
nomenclature	and	display	highly	different	inflammatory	profiles	than	those	previously	described	in	vitro.		
Comparison	of	Ly6Chigh	versus	Ly6Clow	macrophages,	as	well	as	comparison	of	the	same	cell	subset	
with	 time	 revealed	 high	 dynamic	 changes	 of	 gene	 expression	 by	 macrophage	 subsets	 during	 muscle	
regeneration.	 These	 dynamics	 allowed	 to	 highlight	 3	 main	 features	 of	 macrophages	 during	 muscle	
regeneration.	 The	 first	 feature	 is	 early	 expression	 of	 acute	 phase	 proteins	 and	 scavenger	 receptors	 by	
Ly6Chigh	and	Ly6Clow	macrophages,	respectively.	These	macrophages	were	the	most	numerous	at	day	2	and	
they	 highly	 expressed	 a	 series	 of	 genes	 involved	 in	 inflammation.	 Scavenger	 receptors	 are	 thought	 to	
participate	in	the	removal	of	necrotic	debris	in	the	living	body	by	extensive	ligand	specificity	and	a	variety	of	
receptor	molecules.	 Here	we	 show	 that	 Stabilin-1	 is	 upregulated	 in	 the	 Ly6Clow	 fraction	 and	 its	 absence	
significantly	 impacts	 muscle	 regeneration.	 Its	 molecular	 mechanism	 and	 mode	 of	 action	 needs	 further	
investigation.	Second,	expression	of	ECM	components	during	the	early	phase	of	the	regeneration	process.	
Data	 presented	 here	 show	 that	 Ly6Chigh	macrophages	 expressed	 ECM	proteins	 at	 day	 1	 of	 regeneration.	
These	ECM	proteins	are	usually	involved	in	cell-cell	interactions,	intercellular	communication	processes	and	
regulation	of	ECM	organization.	Among	them,	Versican	seems	to	be	involved	and	differentially	regulated	in	
skeletal	muscle	regeneration.	While	the	majority	of	such	molecules	have	been	shown	to	exert	some	effects	
on	macrophages;	mainly	 through	 chemotactic	 activity;	 their	 expression	 by	macrophages	 themselves	 has	
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been	 less	 documented.	 By	 being	 exclusively	 expressed	 on	 day	 1	 Ly6Chigh	MFs	 it	 implies	 that	 it	might	 be	
involved	 in	 the	phenotypic	 transition	of	macrophages.	 In	 addition,	 our	 results	 suggest	 that	macrophages	
may	 directly	 act	 on	 the	 ECM	 environment	 by	 participating	 to	 the	 synthesis	 of	 ECM	 components	 and	
molecules	that	regulate	ECM	constituents.	Further	investigation	would	decipher	the	significance	of	such	an	
expression	 beside	 that	 of	 interstitial	 cells	 at	 the	 early	 phases	 of	 tissue	 healing.	 The	 third	 feature	 is	 the	
metabolic	change	of	macrophages	at	the	time	of	resolution	of	 inflammation.	Between	day	2	and	day	4	of	
regeneration,	Ly6Chigh	macrophages	undergo	a	switch	of	their	phenotype,	to	acquire	an	anti-inflammatory	
phenotype	 and	 become	 Ly6Clow	 cells.	 Apart	 from	 the	 genes	 directly	 linked	 to	 the	 inflammatory	 process	
(chemokines,	cytokines,	etc.),	genes	involved	in	the	regulation	of	cell	metabolism	have	been	shown	to	vary	
according	 to	 the	 inflammatory	 status	 of	 macrophages.	 However,	 while	 metabolism	 is	 foreseen	 as	 an	
important	regulator	of	macrophage	function,	notably	in	diseases,	few	studies	addressed	specific	metabolic	
pathways	 linked	 to	 a	 specific	macrophage	 inflammatory	 status.	 For	 example,	 GDF15	 has	 been	 shown	 to	
prevent	obesity	by	increasing	thermogenesis,	lipolysis	and	oxidative	metabolism.	Here	we	identified	GDF15	
been	 differentially	 upregulated	 during	 the	 repair	 process	 in	 the	 Ly6Clow	 MFs	 and	 its	 absence	 negatively	
impacts	muscle	regeneration.	A	potential	mechanism	by	which	GDF15	exerts	its	action	is	by	directly	acting	
on	satellite	cells	controlling	their	proliferation	and	expansion	following	the	injury.	In	addition,	we	observed	
a	strong	upregulation	of	PPARg,	which	is	characteristic	of	M2	(IL-4)	macrophages	in	vitro,	at	the	late	steps	of	
muscle	regeneration	(day	4)	in	Ly6Clow	macrophages.		
In	this	dissertation,	we	have	identified	the	ligand	activated	transcription	factor,	PPARg	as	a	regulator	
of	macrophage	 functions	 during	muscle	 regeneration.	 By	 using	 two	 distinct	 genetic	models	 (conditional	
macrophage	 specific	 KO	 and	 BMT),	 it	 allowed	 us	 to	 focus	 on	 the	 role	 of	 PPARg	 in	 MFs.	 The	 delay	 in	
regeneration	 in	 PPARg	 deficient	 animals	 was	 profound	 and	 detectable	 as	 long	 as	 three	weeks	 after	 the	
initial	 injury,	thus	appearing	to	be	among	the	most	dramatic	reported	deficiencies	in	regeneration	caused	
by	impairments	in	MF	functions.	 It	 is	 interesting	to	note	that	several	distinct	features	of	the	regeneration	
delay,	such	as	impairment	in	CSA,	and	persistent	presence	of	necrotic	fibers	were	present	after	CTX	injury	in	
PPARg	MacKO	animals.	Systematic	transcriptomic	analyses,	provided	clues	about	both	the	sensory	and	the	
regulatory	roles	of	PPARg	in	muscle	infiltrating	MFs.	We	here	described	several	potential	new	PPARg	target	
genes.	 It	 is	 important	 to	stress	 that	earlier	descriptions	of	direct	PPARg	 target	genes	often	 reported	 lipid	
metabolic	genes	as	the	main	targets	PPARg	of	in	MFs,	which	could	poorly	explain	the	anti-inflammatory	role	
of	the	receptor.	We	report	here	that	the	transcriptional	activity	of	PPARg	is	unique	in	muscle	macrophages,	
because	the	most	robustly	changing	genes	(such	as	Saa3,	Hebp1)	are	linked	to	inflammation,	rather	than	to	
lipid	metabolism.	The	most	intriguing	interpretation	of	the	available	data	would	be	the	involvement	of	a	yet	
unidentified	 endogenous	 ligand	 for	 PPARg	 whose	 activity	 is	 restricted	 to	 the	 Ly6Clow	 compartment.	
Importantly,	PPARg	activity	in	the	Ly6Clow	MF	subtype,	which	dominates	the	regenerative	phase	of	muscle	
injury	suggests	that	PPARg	is	a	licensing	factor	for	repair	MFs.	From	the	perspective	of	muscle	regeneration,	
the	most	important	finding	was	the	identification	of	GDF3,	which	showed	consistent	regulation	by	PPARg	in	
all	 relevant	MF	 subtypes.	 Importantly,	GDF3	 is	 a	 strong	 candidate	 as	 a	MF	derived	paracrine	 factor	with	
muscle	 regenerative	 functions,	 whose	 diminished	 macrophage-linked	 expression	 is	 consistent	 with	 the	
impaired	regeneration	seen	in	PPARg	deficient	animals.	To	link	macrophage	biology	to	tissue	regeneration,	
we	analyzed	the	role	of	MF	derived	GDF3	 in	muscle	regeneration	 in	a	combination	of	 in	vivo	and	 in	vitro	
approaches.	Foremost,	two	genetic	models	of	GDF3	deficiency	(full	body	KO	and	BMT)	reported	a	delay	in	
regeneration.		While	the	decrease	in	average	CSA	in	Gdf3	KO	animals	was	comparable	to	that	seen	in	PPARg	
MacKO	animals,	Gdf3	KO	animals	did	not	display	persistent	inflammation	and	delayed	clearance	of	necrotic	
fibers.	This	suggested	that	PPARg	regulates	several	other	pathways	during	regeneration.	Importantly,	a	gain	
of	 function	 experiment	 revealed	 that	 exogenous	 GDF3	 administered	 locally	 in	 vivo	 could	 counteract	 the	
deleterious	 effect	 of	 PPARg	 deficiency	 in	 MFs.	 In	 addition,	 GDF3	 appeared	 to	 be	 an	 especially	 robust	
enhancer	of	myoblast	differentiation	and	fusion.	Taken	together,	GDF3,	which	is	expressed	in	and	secreted	
by	muscle	 infiltrating	MFs	within	 injured	 and	 regenerating	muscles,	 has	 the	 capacity	 to	 elicit	 biologically	
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relevant	 responses	 in	primary	myoblasts	 and	differentiating	myotubes	and	 is	 a	 regulator	of	both	 in	 vitro	
muscle	 differentiation	 and	 muscle	 regeneration	 in	 vivo.	 As	 other	 cell	 types	 are	 also	 involved	 in	 the	
regeneration	 process,	 it	 cannot	 be	 excluded	 that	 other	 TGFβ	 family	members	 such	 as	 GDF15	 are	 active	
during	regeneration	and	that	it	has	effects	on	other	cell	types	such	as	fibro/adipogenic	progenitors	as	well.		
Our	 findings	 also	 carry	 potential	 implications	 for	 pathological	 circumstances	 in	 which	 muscle	
damage	and	asynchrony	 in	 repair	 due	 to	 aging	 leads	 to	 severe	 impairment	 in	muscle	 function.	Here,	we	
show	that	GDF3	seems	to	be	a	regulator	of	muscle	regeneration	in	geriatric	models	as	well,	which	are	most	
of	the	time	associated	with	the	permanent	presence	of	inflammatory	cells.	These	findings	suggest	that	MF	
derived	factors	such	as	GDF3	and	GDF15	could	also	be	used	as	part	of	other	therapeutics	to	regulate	not	
only	regeneration,	but	also	muscle	and	bone	growth.	 	To	conclude	the	present	work,	so	far,	highlights	an	
unexpected	dynamic	of	the	molecular	signature	of	macrophage	subsets	during	skeletal	muscle	regeneration	
and	 the	 identified	 PPARg	 is	 a	 required	 metabolic	 sensor	 and	 transcriptional	 regulator	 of	 repair	
macrophages,	 that	 controls	 the	 expression	 of	 GDF3,	 which	 in	 turn	 regulates	 the	 restoration	 of	 skeletal	
muscle	 integrity	by	promoting	muscle	progenitor	 cell	 fusion	 (Varga,	Mounier	et	 al.	 2016).	 	However,	our	
understanding	 is	 fairly	 limited	 regarding	 the	 role	of	other	 transcription	 factors	 sensing	 the	macrophage’s	
tissue	 environment	 especially	 in	 the	 context	 of	 epigenetic	 and	 transcriptional	 regulation	 as	 well	 as	
contributing	to	macrophage	effector	functions.	A	logical	extension	to	these	studies	was	to	employ	unbiased	
epigenomic	 profiling,	 to	 identify	 molecules	 regulating	 phenotypic	 transition	 and	 effector	 functions	 of	
inflammatory	and	repair	macrophages.	
The	 phenotypic	 transition	 from	 the	 monocyte	 progenitors	 to	 inflammatory	 Ly6Chigh	 and	 then	 to	
repair	 Ly6Clow	 cells	 is	 highly	 correlated	 with	 the	 tissue	 regeneration	 kinetics	 and	 is	 accompanied	 by	 a	
dynamic	crosstalk	between	macrophages	and	other	muscle	 tissue	components	 that	 lead	 to	a	hierarchical	
chromatin	 and	 transcriptional	 reprogramming	 process.	 In	 order	 to	 delineate	 the	 order	 of	 transcriptional	
events	during	monocyte	infiltration	and	in	situ	macrophage	differentiation	and	to	identify	novel	candidate	
genes	and	signaling	pathways	 regulating	 in	 situ	macrophage	 function	and	 tissue	 regeneration,	we	sought	
first	 to	map	 these	 changes	 by	 generating	 chromatin	 accessibility	maps	 (genomic	 regions	 that	 are	 highly	
bound	 by	 transcription	 complexes)	 using	 the	 ATAC-seq	 method.	 By	 using	 ATAC-seq	 on	 circulating	
monocytes	 and	muscle	 infiltrating	macrophages	 from	day	 1,	 2	 and	 4,	 detection	 of	 differentially	 opening	
sites	in	time	allowed	us	to	expand	our	analysis	and	look	for	the	actual	transcriptional	regulators	that	might	
be	 responsible	 for	 these	 changes.	 Coupling	 standard	 bioinformatic	 analysis	 with	 innovative	 clustering	
algorithms,	we	 found	 that	 a	 large	 class	of	more	 than	9000	 genomic	 regulatory	 elements	 is	 becoming	de	
novo	accessible	during	monocyte	infiltration	in	the	muscle.	 Importantly,	motif	analysis	showed	that	these	
sites	were	very	highly	enriched	(58%	of	sites)	to	AP-1	motif	(including	the	Maf	recognition	element	-	MARE)	
compared	to	other	common	macrophage	specific	motifs	(PU.1,	C/EBP).	This	intriguing	finding	prompted	us	
to	 ask	 the	 following	 questions:	 1)	what	 are	 the	 AP-1	motif	 binding	 transcription	 factors	 that	 potentially	
regulate	 these	de	novo	accessible	 sites,	and	2)	how	these	AP-1	 factors	contribute	overall	 to	macrophage	
polarization	 during	muscle	 regeneration.	 Potential	 candidates	would	 include	 known	AP-1	 factors	 such	 as	
Jun,	Fos,	NF-E2	and	others	that	have	been	shown	to	form	homo-	or	hetero-	dimers	to	activate	their	gene	
targets.	However,	such	factors	are	usually	inducible	and	bind	to	DNA	by	continuously	competing	with	other	
AP-1	 family	members.	This	mode	of	action	 is	 interesting	as	 it	 suggests	 that	 repressor	 factors	bind	 to	 low	
accessible	sites	and	precede	activators	and	that	such	early	chromatin	priming	by	bookmarking	transcription	
factors	might	be	important	to	activator	recruitment	and	thus	to	the	effective	control	of	transient	activation	
programs.	We	hypothesized	that	such	transcription	factors	are	in	place	in	our	experimental	system	and	we	
set	the	following	criteria	to	narrow	down	candidate	regulator	transcription	factors:	1)	ability	to	bind	AP-1	
motifs	with	repressor	activity,	2)	high	expression	in	monocytes	and	macrophage	populations	and	3)	direct	
sensor	of	cellular	environment	changes	(such	as	metabolite	concentration	changes).	It	has	been	shown	that	
during	muscle	damage,	profound	changes	in	the	muscle	expression	of	heme	and	iron	gene	can	be	observed.	
Muscle-infiltrating	macrophages	carry	out	this	function	thus	preventing	the	deleterious	effects	caused	by	its	
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oxidizing	 action.	 In	 addition,	 the	 ability	 of	 infiltrating	macrophages	 to	 export	 iron	 is	 crucial	 to	 avoid	 fat	
accumulation	during	the	regeneration	process.	Myoglobin,	which	is	released	because	of	the	muscle	necrosis	
possibly	 influences	 the	expression	of	 iron	homeostatic	 genes	which	 in	 turn	might	 reflect	on	macrophage	
phenotype	switch.	Thus,	based	both	on	 literature	search	and	available	 transcriptomic	data,	we	narrowed	
down	to	the	heme	sensing	transcription	factor	BACH1.	
The	transcription	factor	BACH1	forms	heterodimers	with	small	Maf	proteins	that	binds	to	the	Maf	
recognition	 element	 (MARE),	 a	 subcategory	 of	 AP-1	 motif,	 to	 act	 as	 transcription	 repressor.	 BACH1	 is	
expressed	 in	 most	 cell	 types,	 but	 it	 is	 more	 highly	 upregulated	 in	 hematopoietic	 cells	 (macrophages,	
dendritic	cells	and	thymic	T	cells).	Notably,	BACH1	possesses	a	heme-binding	region	and	thus	can	be	directly	
bound	by	 free	 heme	 that	 is	 released	by	many	hemoproteins	 such	 as	 hemoglobin	 and	myoglobin	 usually	
following	acute	tissue	damage.	Heme	binding	destabilizes	BACH1,	thus	inhibiting	its	DNA	binding	capacity,	
and	 subsequently	 BACH1	 is	 exported	 from	 nucleus	 and	 degraded	 in	 the	 proteasome.	 Subsequently,	 the	
transcription	 factor	 NF-E2,	 competing	 for	 the	 same	 MARE	 sites,	 heterodimerizes	 with	 small	 Mafs	 and	
activates	BACH1	target	genes,	such	as	the	heme	oxygenase	1	enzyme	(Hmox1)	to	further	degrade	heme	to	
less	 harmful	 metabolites,	 biliverdin,	 ferrous	 iron,	 and	 carbon	 monoxide.	 Absence	 of	 BACH1	 leads	 to	
constitutive	expression	of	Hmox1.	Thus,	according	to	existing	 literature,	BACH1	functions	as	a	metabolite	
driven	regulator	of	heme	and	iron	metabolism,	metal	detoxification	and	cellular	signaling	programs.	BACH1	
has	 largely	 an	 invariable	 gene	 expression	 profile	 among	 different	 populations	 of	 macrophages	 and,	
interestingly,	 it	 has	 been	 predicted	 by	 transcriptomic	 analysis	 of	 the	 Immunological	 Genome	 Project	
(Immgen)	to	be	among	the	core	regulator	of	macrophage	identity,	along	with	TCEF3,	C/EBP-α,	and	CREG-1.	
However,	 contrary	 to	expectations	based	on	 its	 importance	and	ubiquitous	presence,	 the	existing	mouse	
model	 has	 minimal	 macrophage	 developmental	 defect	 and	 no	 overall	 physiological	 defects	 in	 mouse	
development	 and	 lifespan.	 In	 addition,	 in	 experimental	 injury	 and	 inflammatory	 models,	 these	 animals	
show	protective	phenotypes	 and	dampened	overall	 inflammatory	 responses.	 To	 test	 our	hypothesis	 that	
the	heme-BACH1-Hmox1	axis	contributes	to	macrophage	function	during	muscle	 injury	and	regeneration,	
we	performed	CTX	experiments	in	heme	treated,	Bach1	KO	and	Hmox1	conditional	KO	mice.	Histology	and	
morphometric	 analysis	 showed	 that	 these	 mice	 have	 delayed	 muscle	 repair	 and	 regeneration	 kinetics	
(extensive	 and	 persistent	 necrotic	 content	 in	 the	 muscle	 tissue	 and	 smaller	 mean	 muscle	 fiber	 size	
compared	 to	 controls).	 Bone	marrow	 transplantation	 experiments	 showed	 that	 this	 defect	 is	 intrinsic	 to	
myeloid	cells	and	not	attributed	to	BACH1	function	in	muscle	cells.	FACS	analysis	showed	comparable	cell	
numbers	of	infiltrating	myeloid	cells	but	a	reproducible	higher	(in	the	case	of	Bach1	KO	and	heme	treated	
mice)	 or	 lower	 (in	 the	 case	 of	 the	 macrophage	 conditional	 Hmox1	 KO)	 ratio	 of	 repair	 (Ly6Clow)	 to	
inflammatory	(Ly6Chigh)	macrophages	at	day	4	post	CTX.	To	our	knowledge	only	three	other	experimental	
systems	(DUSP1,	AMPKa1	or	IGF1	deficiency	in	muscle	infiltrative	MFs)	were	reported	to	lead	to	altered	MF	
differentiation.	
Complementary	to	this	in	vivo	analysis	and	to	gain	insights	to	the	molecular	function	of	BACH1,	we	
used	eRNA	measurements,	 and	 the	BMDM	differentiation	 system	 to	map	BACH1	novel	binding	 sites	and	
potential	 target	genes	using	ChIP.	We	 found	 that	BACH1	binds	 to	a	 large	number	of	activated	enhancers	
and	accessible	sites	in	the	genome	based	on	the	ATAC-seq	mapping.	Importantly,	BACH1	extensively	binds	
to	 a	 number	 of	 gene	 loci	 (Il6,	 Il10,	 Cebpb,	 Dusp1,	 PPARg,	 Igf1,	 Slc40a1,	 GDF3)	 previously	 shown	 to	
participate	 and	heavily	 impact	 the	 regeneration	process.	 These	observations	 expand	 the	 current	 view	of	
BACH1	as	mere	rheostat	of	heme-oxygenase	1	expression	and	potentially	suggest	BACH1	involvement	in	a	
bookmarking	mechanism	 of	 genomic	 sites	 yet	 to	 be	 activated	 in	macrophages	when	 appropriate	 signals	
become	present	or	of	an	active	repressing	mode	action	to	genomic	regions,	active	in	other	cellular	states,	
environments	or	lineages.	Taken	together,	these	results	suggest	that	proper	muscle	regeneration	depends	
on	tightly	and	timely	regulated	inflammatory	responses	following	acute	injury	and	that	BACH1	likely	acts	to	
fine-tune	 activation,	 phenotypic	 transition	 and	 resolution	 of	 inflammatory	 programs.	 Lastly,	 BACH1’s	
protein	 structure	 and	 capacity	 to	 bind	metabolites	 and	 sense	 the	 tissue	micro-environment	makes	 it	 an	
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attractive	 model	 to	 test	 how	 such	 signal	 integrators	 sense	 different	 tissue	 stimuli	 and	 shape	 different	
transcriptional	programs	and	diverse	macrophage	subtypes.			
Tissue	 regeneration	 is	 a	 complex	 but	 precisely	 coordinated	 array	 of	 processes	 involving	 cellular	
recruitment,	 differentiation,	 phenotype	 switches,	 and	 intercellular	 communications.	 It	 is	 remarkable,	
though,	 that	 the	 key	 elements	 of	 the	myogenic	 cross	 talk	 between	macrophages	 and	myoblasts	 suggest	
that	these	two	cell	types	and	their	interactions	are	critical	to	support	regeneration.	In	the	final	part	of	this	
work,	we	document	that	(1)	altered	cellular	composition	affects	the	in	situ	phenotypic	transition	of	invading	
myeloid	 cells	 to	 repair	 macrophages,	 thus	 (2)	 revealing	 the	 existence	 of	 reciprocal	 intercellular	
communication	between	satellite	cells	and	recruited	macrophages	during	skeletal	muscle	regeneration,	and	
(3)	 establish	a	 combination	of	methods	 to	use	bone	marrow	 transplantation,	with	 local	muscle	 radiation	
shielding,	 to	 identify	myeloid	 cell	 contribution	 to	 tissue	 repair	 and	monitor	 the	myeloid	 cells	 metabolic	
activity	in	vivo.	
As	 mentioned	 several	 times	 in	 this	 work	 the	 skeletal	 muscle	 microenvironment	 is	 very	
heterogeneous,	 with	 distinct	 cell	 types	 such	 as	 satellite	 cells,	 fibroblasts,	 fibro/adipogenic	 progenitors	
(FAPs)	adipocytes,	epithelial	cells,	Schwann	cells,	and	blood	cells,	all	of	which	may	influence	and,	in	turn,	be	
influenced	 by	 local	 structural	 and	 biochemical	 cues.	 The	 general	 consensus	 holds	 that	 satellite	 cells	 are	
required	 for	muscle	 regeneration.	 Here	we	 show	 that	 both,	 radiation-induced	 or	 in	 vivo	 ablation	 (PAX7-
DTA)	 of	 these	 cells,	 leads	 to	 delayed	 repair	macrophage	 phenotypic	 transition	 and	muscle	 regeneration.	
While	 there	have	been	several	papers	demonstrating	 that	 infiltrating	macrophages	 influence	satellite	cell	
behavior,	our	data	indicate	that	the	reverse	is	also	true,	and	that	Pax7-lineage	cells	are	regulating	a	degree	
of	the	in-situ	macrophage	phenotypic	shift.	However,	there	are	also	additional	cell	types	that	are	abundant	
in	 healthy	 muscle,	 and	 it’s	 been	 recently	 shown	 that	 FAPs,	 fibroblasts,	 endothelial	 cells,	 and	 other	
interstitial	 cells	 like	 pericytes,	 expand	 following	 acute	 muscle	 damage,	 to	 transiently	 establish	 an	
environment	 that	 enhances	myogenic	 differentiation.	 This	 raises	 the	 question	 whether	 perturbations	 of	
their	cellular	interplay	with	satellite	cells	or	macrophages	could	further	explain	the	delay	in	the	macrophage	
phenotype	switch.	For	example,	it	 is	known	that	angiogenesis	is	crucial	for	muscle	repair	and	satellite	cell	
survival.	 In	 this	 context,	 endothelial	 cells	 strongly	 stimulate	 myogenic	 cell	 growth	 while	 myogenic	 cells	
promote	angiogenesis.	On	the	other	hand,	during	return	to	homeostasis,	periendothelial	cells	facilitate	the	
return	 to	 quiescence	 of	 a	 subset	 of	muscle	 precursor	 cells	 that	 ensures	 self-renewal	 of	 the	 satellite	 cell	
pool.	Interestingly,	depletion	of	PAX7+	cells	 in	vivo	has	no	impact	on	vasculature	(CD31+	endothelial	cells),	
innervation	or	 neuromuscular	 junctions.	 The	 same	group	 also	documented	 that	 FAPs	 and	 fibroblasts	 are	
unchanged	 in	 the	 PAX7+	 ablated	 muscles,	 which	 suggests	 that	 the	 interaction	 of	 satellite	 cells	 with	
macrophages	is	unique	and	likely	to	be	specific.		
Our	findings	that	PAX7	positive	satellite	cells	affect	macrophage	phenotypic	transition	poses	several	
more	 questions,	 regarding	 a	 potential	 niche	 for	 macrophages	 formed	 by	 satellite	 cells,	 what	 signaling	
molecules/cytokines	 influence	 the	 communication	 between	 these	 cell	 types	 and	 whether	 satellite	 cells	
produce	signals	that	instruct	macrophage	functions	such	debris	clearance,	phagocytosis	and	myogenesis.	It	
will	require	selective	depletion	or	replenishment	of	satellite	cells	and	other	cell	types	to	establish	the	cause	
and	effect	relationships	between	them	and	macrophage	invasion,	phenotypic	switching	and	contribution	to	
repair.	Future	studies	should	test	whether	radiation	causes	a	depletion	of	these	and	other	local	interstitial	
cells	with	myogenic	potential	 that	 could	 affect	 also	 the	 cross	 talk	with	 the	 immune	 cells	 following	acute	
damage,	which	 in	 turn	 can	 affect	macrophage	 infiltration	 and	 phenotypic	 dynamics.	 In	 this	 context,	 our	
data	suggest	that	the	delayed	transition	is	likely	to	be	causative	of	impaired	regeneration.	
Several	important	signaling	pathways	and	transcriptional	regulators	such	as	IGF-1,	CEBPb,	AMPKa1	
and	P-38/MKP,	have	been	implicated	in	the	phenotypic	transition	of	these	muscle	macrophages	(from	the	
pro-inflammatory/phagocytic	 phenotype	 (Ly6Chigh)	 to	 the	 anti-inflammatory/reparatory	 phenotype	
(Ly6Clow))	 using	 the	 CTX	 model.	 However,	 many	 more	 pathways	 could	 be	 implicated	 and	 further	 work	
towards	 their	 identification	 is	needed.	To	 this	end,	 loss	of	 function	experiments,	have	been	employed	 to	
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identify	key	genes,	by	crossing	gene	specific	floxed	allele	containing	mice	with	the	myeloid-specific	LysM-
CRE	strain,	in	order	to	generate	myeloid-specific	knock	out	strains.	However,	the	availability	of	conditional	
myeloid	 specific	 knockout	 mice	 for	 most	 genes	 is	 a	 limiting	 factor	 in	 delineating	 their	 role	 in	 the	
macrophage	phenotype	switch	during	muscle	injury	and	regeneration.	A	commonly	used	method	to	assess	
the	 contribution	 of	 myeloid	 cell	 populations	 in	 in	 vivo	 murine	 disease	 models	 is	 bone	 marrow	
transplantation	 (BMT).	During	 this	CD45	 congenic	method,	 the	bone	marrow	of	 animals	 is	 eliminated	by	
total	body	irradiation	and	then	reconstituted	by	injecting	a	fresh	bone	marrow	isolated	from	specific	donor	
animals	 that	 are	 usually	 genetically	 manipulated.	 The	 fact	 that	 the	 congenic	 donor	 cells	 can	 be	 easily	
tracked	 is	 also	 highly	 beneficial.	 However,	 the	 requirement	 for	 total	 body	 irradiation	 leads	 to	 unwanted	
inflammation,	 tissue	 injuries	 and	 fibrosis	 if	 not	 properly	 optimized.	 Therefore,	 we	 reasoned	 that	 the	
combination	of	an	optimized	BMT	method	with	dose	 fractionation	and	 in	vivo	 imaging	would	allow	us	to	
trace	 and	 characterize	myeloid	 cell	 invasion	 and	 cellular	 interactions	 and	 overcome	 the	 radiation	 effect.	
Low	radiation	doses	 lead	to	 incomplete	engraftment	due	to	survival	of	the	host	bone	marrow,	but	at	the	
same	time	can	also	lead	to	macrophage	activation.	Thus,	an	optimum	radiation	dose	is	needed	to	achieve	
complete	 BM	 ablation	 without	 causing	 any	 local	 organ	 damage.	 According	 to	 the	 current	 literature	
irradiation	doses	of	7	to	13	Gy	are	myeloablative	but	one	needs	to	be	aware	that	the	higher	the	dose,	the	
higher	 the	 risk	 for	 the	animals	 to	die	 from	 irradiation-induced	 toxicity.	As	mentioned	above	methods	 for	
reducing	radiation	toxicity	include	dose	fractionation	(in	which	smaller	doses	of	radiation	are	administered	
sequentially)	and	lead	shielding.	The	latter	method	was	successfully	used	by	Labar	et	al	and	Murphy	et	al.	to	
protect	the	lungs	and	study	alveolar	macrophage	turnover	following	BMT,	but	were	limited	by	high	levels	of	
mixed	chimerism	in	the	circulation	due	to	head	and	forelimbs	being	lead	shielded	as	well.	In	our	study	and	
in	order	to	bypass	these	limitations,	(1)	we	used	radioprotection	sparingly,	focused	on	protecting	only	one	
hindlimb	 (to	 minimize	 radioprotection	 of	 the	 recipient	 animal’s	 BM),	 (2)	 increase	 the	 number	 of	
transplanted	 cells	 to	 20x106	 cells/BMT	 animal	 in	 order	 to	 increase	 the	 degree	 of	 chimerism	 in	 favor	 of	
donor	BM	repopulation	(hindlimb	radioprotection	increases	survival	of	host	BM	that	 in	turn	increases	the	
competition	with	the	donor	BM),	and	(3)	 increase	recovery	time	to	12	weeks	post	BMT,	thus	allowing	us,	
both	 to	 reach	 high	 levels	 of	 blood	 chimerism	 (>90%)	 and	 protect	 the	 local	 radiosensitive	 muscle	
compartments	(e.g.	satellite	cell	pool).		
Our	 combined	method	with	 in	 vivo	 tracing	 of	myeloid	 cells	 by	 PET-MRI	 is	 an	 important	 advance	
allowing	 real	 time	 assessment	 of	 cell	 invasion	 as	 opposed	 to	 cell	 sorting	 that	 requires	 several	 hours	 of	
processing.	These	findings	have	general	ramifications	because	it	may	be	possible	to	extend	the	utility	of	this	
system	to	other	organs,	for	studies	that	require	preservation	of	resident	cell	populations	 in	bone	marrow	
transplanted	animals,	and	especially	in	cases	of	immune	cell	invasion.	In	addition,	this	method	allowed	us	to	
examine,	monitor	and	characterize	the	immune	cell	invasion	following	acute	injury	by	CTX.	The	PET-MRI	in	
vivo	 imaging	 studies	 showed	 that	 these	 invading	 cells	 seem	 to	 have	 special	metabolic	 properties	 biased	
towards	 glycolysis.	 Our	 findings	 suggest	 that	 18F-FDG	 PET-MRI	 is	 a	 useful	 tool	 to	 monitor	 immune	 cell	
invasion	 and	 to	 help	 to	 delineate	 and	 further	 explain	 the	 difference	 in	 the	 regeneration	 process	 in	 the	
irradiated	 muscles	 and	 especially	 the	 difference	 between	 BMT-shielded	 and	 BMT-unshielded	 muscles.	
Further	acute	sterile	injury	models	in	other	tissues,	such	as	liver	or	skin	injury,	could	validate	our	PET-MRI	
results.	
In	conclusion,	our	work	has	 translational	 implications	on	 the	muscle	 regenerative	potential	of	 the	
elderly	following	radiation	therapy.	Our	findings	suggest	that	irradiation	of	skeletal	muscle	might	impair	the	
ability	 of	 satellite	 cells	 to	 orchestrate	macrophage	 phenotypic	 transition	 further	 impacting	 regeneration	
potential.	This	is	in	addition	to	other	known	side	effects	of	irradiation	such	as	direct	effects	on	myoblasts.	
Our	findings	also	convey	potential	 ramifications	for	pathological	circumstances	 in	which	recurrent	muscle	
damage	and	satellite	cell	mediated	regeneration	asynchrony	leads	to	devastating	muscle	diseases,	such	as	
Duchenne	Muscular	Dystrophy,	which	are	usually	associated	with	the	permanent	presence	(and	potential	
interaction)	 of	 inflammatory	 cells,	 especially	 macrophages.
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Summary	
	
Skeletal	muscle	 regeneration	 is	 a	 complex	 interplay	between	various	 cell	 types	 including	 invading	
macrophages.	 Their	 recruitment	 to	 damaged	 tissues	 upon	 acute	 sterile	 injuries	 is	 necessary	 for	 necrotic	
debris	clearance	and	for	coordination	of	tissue	regeneration.	This	highly	dynamic	process	 is	characterized	
by	 an	 in	 situ	 transition	 of	 infiltrating	 monocytes	 from	 an	 inflammatory	 (Ly6Chigh)	 to	 a	 repair	 (Ly6Clow)	
macrophage	 phenotype.	 System-level	 gene	 expression	 analysis	 revealed	 that	 the	 time	 course	 of	muscle	
regeneration,	much	more	 than	 Ly6C	 status,	was	 correlated	with	 the	 largest	 differential	 gene	 expression.	
This	indicated	that	the	time	course	of	inflammation	was	the	predominant	driving	force	of	macrophage	gene	
expression.	These	findings	validate	the	dynamic	nature	of	the	macrophage	response	and	associate	a	specific	
gene	 signature	 to	 predictive	 specialized	 functions	 of	macrophages	 at	 each	 step	 of	muscle	 regeneration.	
However,	 the	 gene	 regulatory	 events	 supporting	 the	 sensory	 and	 effector	 functions	 of	 macrophages	
involved	in	tissue	repair	are	not	well	understood.	Here,	we	show	that	the	lipid	activated	transcription	factor	
(TF),	 PPARg	 is	 required	 for	proper	 skeletal	muscle	 regeneration	 acting	 in	 repair	MFs.	 PPARg	 controls	 the	
expression	of	 the	TGFβ	 family	member,	GDF3,	which	 in	 turn	 regulates	 the	 restoration	of	 skeletal	muscle	
integrity	 by	 stimulating	myoblast	 cell	 fusion.	 In	 addition,	 to	delineate	 the	order	of	 transcriptional	 events	
during	monocyte	 infiltration	and	 in	 situ	macrophage	differentiation	we	generated	 chromatin	accessibility	
maps	using	ATAC-seq.	We	 found	 that	 a	 large	 class	of	 genomic	 regulatory	elements	 is	 becoming	de	novo	
accessible	during	monocyte	infiltration	in	the	muscle,	and	motif	analysis	showed	that	these	sites	are	highly	
enriched	to	the	MARE	motif,	compared	to	other	common	macrophage	specific	motifs.	We	also	 identified	
BACH1,	 a	 heme-regulated	 MARE-binding	 TF,	 as	 a	 novel	 regulatory	 molecule.	 The	 contribution	 of	 this	
molecule	and	downstream	targets	such	as	Hmox1,	have	been	evaluated	using	full	body	and	macrophage-
specific	knock-outs.	Surprisingly,	the	inactivation	of	either	Bach1	or	Hmox1	in	macrophages	impairs	muscle	
regeneration	by	altering	the	dynamics	of	the	macrophage	phenotypic	transition.	In	addition,	Bach1	deletion	
leads	 to	 transcriptional	deregulation	of	 critical	 inflammatory	genes	 in	macrophages	upon	 injury.	By	using	
bone	marrow-derived	macrophages,	 we	 found	 BACH1	 to	 bind	 extensively	 to	 enhancers	 of	 these	 genes,	
suggesting	 that	 fine-tuning	 of	 transient	 inflammatory	 transcriptional	 programs	 in	 macrophages	 during	
tissue	 injury,	 largely	 depend	 on	 MARE-binding	 TFs.	 Overall,	 this	 work	 establishes	 PPARg	 and	 BACH1	 as	
required	environment	sensors	and	transcriptional	regulators	of	muscle	infiltrating	MFs.	Moreover,	this	work	
also	 establishes	 GDF3	 as	 a	 secreted	 extrinsic	 effector	 protein	 acting	 on	 myoblasts	 and	 serving	 as	 a	
regeneration	factor	in	tissue	repair.		 	
The	importance	of	the	macrophage	phenotypic	shift	and	the	cell	cross-talk	of	the	local	muscle	tissue	
with	the	infiltrating	macrophages	during	tissue	regeneration	upon	injury	are	also	not	fully	understood	and	
their	 study	 lacks	 adequate	 methodology.	 Here,	 by	 using	 an	 acute	 sterile	 skeletal	 muscle	 injury	 model	
combined	 with	 irradiation,	 bone	 marrow	 transplantation	 and	 in	 vivo	 imaging	 we	 show	 that	 preserved	
muscle	 integrity	 and	 cell	 composition	 prior	 to	 the	 injury	 is	 necessary	 for	 repair	macrophage	 phenotypic	
transition	and	subsequently	for	proper	and	complete	tissue	regeneration.	Importantly,	by	using	a	model	of	
in	 vivo	 ablation	 of	 PAX7	 positive	 cells,	 we	 show	 that	 this	 radiosensitive	 skeletal	muscle	 progenitor	 pool	
contributes	to	macrophage	phenotypic	transition	following	acute	sterile	muscle	injury.	Taken	together,	our	
data	 suggest	 the	 existence	 of	 a	 more	 extensive	 and	 reciprocal	 cross-talk	 between	 muscle	 tissue	
compartments,	including	satellite	cells,	and	infiltrating	myeloid	cells	upon	tissue	damage.	These	interactions	
are	 shaping	 the	 macrophages	 in-situ	 phenotypic	 shift,	 which	 is	 indispensable	 for	 normal	 muscle	 tissue	
repair	dynamics.	
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